FamiCord Group Nakiller
Filter by:
| No. | Cell source | Indication | Area of medicine | Year | Type of therapy | Country | Age | |
|---|---|---|---|---|---|---|---|---|
| 1 | cord blood | allogeneic - sibling | talassemia | hematology | 2019 | standard therapy | Turkey | 6 |
| 2 | cord blood | autologous | autism | neurology | 2019 | experimental therapy | Poland | 3 |
| 3 | cord blood | allogeneic - sibling | talassemia | hematology | 2019 | standard therapy | Turkey | 6 |
| 4 | cord blood | autologous | autism | neurology | 2018 | experimental therapy | USA | 8 |
| 5 | cord blood | autologous | autism | neurology | 2018 | experimental therapy | USA | 6 |
| 6 | cord blood | autologous | cerebral palsy | neurology | 2018 | experimental therapy | USA | 1 |
| 7 | cord blood | allogeneic - sibling | sickle cell anemia | hematology | 2018 | standard therapy | Turkey | 10 |
| 8 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 10 |
| 9 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 5 |
| 10 | cord blood | allogeneic - sibling | autism | neurology | 2018 | experimental therapy | Poland | 3 |
| 11 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 4 |
| 12 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 4 |
| 13 | cord blood | allogeneic - sibling | talassemia major | hematology | 2018 | standard therapy | Turkey | 9 |
| 14 | cord blood | autologous | aplastic anaemia | hematology | 2018 | standard therapy | Poland | 3 |
| 15 | cord blood | allogeneic - sibling | chronic granulomatous disease | hematology | 2017 | standard therapy | Turkey | 3 |
| 16 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 4 |
| 17 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 4 |
| 18 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 5 |
| 19 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 7 |
| 20 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 6 |
| 21 | cord blood | autologous | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
| 22 | cord blood | allogeneic - sibling | relapse of acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 7 |
| 23 | cord blood | autologous | autism | neurology | 2017 | experimental therapy | Poland | 4 |
| 24 | cord blood | autologous | cerebral palsy | neurology | 2017 | experimental therapy | USA | 7 |
| 25 | cord blood | autologous | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 10 |
| 26 | cord blood | autologous | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
| 27 | cord blood | autologous | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
| 28 | cord blood | allogeneic - sibling | talassemia major | hematology | 2017 | standard therapy | Turkey | 4 |
| 29 | cord blood | allogeneic - sibling | talassemia major | hematology | 2017 | standard therapy | Turkey | 4 |
| 30 | cord blood | allogeneic - sibling | CD40 ligand deficiency | hematology | 2017 | standard therapy | Turkey | 9 |
| 31 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Hungary | 7 |
| 32 | cord blood | autologous | autism | neurology | 2016 | experimental therapy | Poland | 6 |
| 33 | cord blood | allogeneic - unrelated | acute myeloid leukemia | hematology | 2016 | standard therapy | Jordan | 6 |
| 34 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2015 | standard therapy | Poland | 4 |
| 35 | cord blood | autologous | acute myeloid leukemia | hematology | 2014 | standard therapy | Spain | 6 |
| 36 | cord blood | allogeneic - unrelated | acute lymphoblastic leukemia | hematology | 2014 | standard therapy | Columbia | 15 |
| 37 | cord blood | autologous | cerebral palsy | neurology | 2014 | experimental therapy | Spain | 4 |
| 38 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2014 | standard therapy | Turkey | 7 |
| 39 | cord blood | allogeneic - sibling | X - linked lymphoproliferative syndrome | hematology | 2013 | standard therapy | Poland | below 1 |
| 40 | cord blood | allogeneic - sibling | beta-talassemia; agranulocytosis | hematology | 2013 | standard therapy | Turkey | 8 |
| 41 | cord blood | allogeneic - sibling | acute myeloid leukemia | hematology | 2013 | standard therapy | Poland | 3 |
| 42 | cord blood | allogeneic - sibling | aplastic anaemia | hematology | 2013 | standard therapy | Poland | 3 |
| 43 | cord blood | autologous | cerebral palsy | neurology | 2012 | experimental therapy | USA | 3 |
| 44 | cord blood | allogeneic - sibling | T-acute lymphoblastic leukemia | hematology | 2012 | standard therapy | Turkey | 5 |
| 45 | cord blood | allogeneic - sibling | talassemia major, acute lymphoblastic leukemia | hematology | 2012 | standard therapy | Turkey | 3 |
| 46 | cord blood | allogeneic - sibling | anaemia, talassemia major | hematology | 2012 | standard therapy | Turkey | 6 |
| 47 | cord blood | allogeneic - sibling | severe aplastic anaemia | hematology | 2012 | standard therapy | Hungary | 3 |
| 48 | cord blood | autologous | cerebral palsy | neurology | 2011 | experimental therapy | USA | 6 |
| 49 | cord blood | allogeneic - sibling | chronic granulomatous disease | hematology | 2011 | standard therapy | Poland | 7 |
| 50 | cord blood | allogeneic - sibling | histiocytosis | hematology | 2011 | standard therapy | Poland | 2 |
| 51 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2011 | standard therapy | Poland | 5 |
| 52 | cord blood | allogeneic - sibling | acute myeloid leukemia | hematology | 2011 | standard therapy | Hungary | 2 |
| 53 | cord blood | allogeneic - sibling | Fanconi anemia | hematology | 2011 | standard therapy | Poland | 12 |
| 54 | cord blood | autologous | cerebral palsy | neurology | 2010 | experimental therapy | USA | 6 |
| 55 | cord blood | autologous | cerebral palsy | neurology | 2010 | experimental therapy | USA | 1 |
| 56 | cord blood | autologous | cerebral palsy | neurology | 2010 | experimental therapy | USA | 1 |
| 57 | cord blood | allogeneic - sibling | pre -B acute lymphoblastic leukemia | hematology | 2010 | standard therapy | Hungary | 1 |
| 58 | cord blood | autologous | cerebral palsy | neurology | 2009 | experimental therapy | USA | 2 |
| 59 | cord blood | autologous | cerebral palsy | neurology | 2009 | experimental therapy | USA | 2 |
| 60 | cord blood | allogeneic - sibling | myelodysplastic syndrome | hematology | 2009 | standard therapy | Poland | 5 |
| 61 | cord blood | autologous | cerebral ischemia | neurology | 2008 | experimental therapy | Poland | 1 |
| 62 | cord blood | allogeneic - sibling | acute lymphoblastic leukemia | hematology | 2008 | standard therapy | Poland | 5 |
| 63 | cord blood | allogeneic - sibling | SCID, severe combined immunodeficiency | hematology | 2007 | standard therapy | Portugal | 1 |
| 64 | cord blood | allogeneic - sibling | neuroblastoma | hematology | 2007 | standard therapy | Poland | 8 |
| 65 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 59 |
| 66 | cord tissue (Wharton's jelly) | allo-related | encephalopathy; cerebral palsy | neurology | 2019 | experimental therapy | Poland | 6 |
| 67 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 9 |
| 68 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 46 |
| 69 | cord tissue (Wharton's jelly) | allo-unrelated | degeneration of the cartilage of the knee joint | orthopedics | 2019 | experimental therapy | Poland | 44 |
| 70 | cord tissue (Wharton's jelly) | allo-unrelated | arthrosis of the knee joint; chondromalacia | orthopedics | 2019 | experimental therapy | Poland | 51 |
| 71 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy; global developmental delay | neurology | 2019 | experimental therapy | Poland | 4 |
| 72 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2019 | experimental therapy | Poland | 5 |
| 73 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 5 |
| 74 | cord tissue (Wharton's jelly) | allo-unrelated | general hypotonia | neurology | 2019 | experimental therapy | Poland | 2 |
| 75 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2019 | experimental therapy | Poland | 59 |
| 76 | cord tissue (Wharton's jelly) | allo-unrelated | macular degeneration | ophthalmology | 2019 | experimental therapy | Poland | 15 |
| 77 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 39 |
| 78 | cord tissue (Wharton's jelly) | allo-unrelated | ischemic stroke | neurology | 2019 | experimental therapy | Poland | 40 |
| 79 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 24 |
| 80 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2019 | experimental therapy | Poland | 49 |
| 81 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy; microcephalia | neurology | 2019 | experimental therapy | Poland | 9 |
| 82 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 7 |
| 83 | cord tissue (Wharton's jelly) | allo-unrelated | choroirodermia | ophthalmology | 2019 | experimental therapy | Poland | 24 |
| 84 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2019 | experimental therapy | Poland | 7 |
| 85 | cord tissue (Wharton's jelly) | allo-unrelated | Krabbe disease | neurology | 2019 | experimental therapy | Poland | 3 |
| 86 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 6 |
| 87 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2019 | experimental therapy | Poland | 61 |
| 88 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2019 | experimental therapy | Poland | 1 |
| 89 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development; congenital cytomegaly | neurology | 2019 | experimental therapy | Poland | 8 |
| 90 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; developmental delay | neurology | 2019 | experimental therapy | Poland | 18 |
| 91 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; Dandy-Walker malformation | neurology | 2019 | experimental therapy | Poland | 7 |
| 92 | cord tissue (Wharton's jelly) | allo-unrelated | Friedreich's ataxia | neurology | 2019 | experimental therapy | Poland | 59 |
| 93 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 4 |
| 94 | cord tissue (Wharton's jelly) | allo-unrelated | Angelman syndrome; cerebral palsy | neurology | 2019 | experimental therapy | Poland | 13 |
| 95 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 65 |
| 96 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 9 |
| 97 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 6 |
| 98 | cord tissue (Wharton's jelly) | allo-unrelated | status after meningitis and encephalitis; encephalopathy | neurology | 2019 | experimental therapy | Poland | 4 |
| 99 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 2 |
| 100 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 8 |
| 101 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 15 |
| 102 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2019 | experimental therapy | Poland | 7 |
| 103 | cord tissue (Wharton's jelly) | allo-unrelated | myelomeningocele | neurology | 2019 | experimental therapy | Poland | 2 |
| 104 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 1 |
| 105 | cord tissue (Wharton's jelly) | allo-related | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 2 |
| 106 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 7 |
| 107 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 58 |
| 108 | cord tissue (Wharton's jelly) | allo-unrelated | secondary progressive multiple sclerosis | neurology | 2019 | experimental therapy | Poland | 54 |
| 109 | cord tissue (Wharton's jelly) | allo-unrelated | secondary progressive multiple sclerosis | neurology | 2019 | experimental therapy | Poland | 64 |
| 110 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 73 |
| 111 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2019 | experimental therapy | Poland | brak danych |
| 112 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 38 |
| 113 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2019 | experimental therapy | Poland | 67 |
| 114 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 4 |
| 115 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia; developmental delay | neurology | 2019 | experimental therapy | Poland | 3 |
| 116 | cord tissue (Wharton's jelly) | allo-related | sclerosis multiplex | neurology | 2019 | experimental therapy | Poland | 61 |
| 117 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
| 118 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
| 119 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
| 120 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
| 121 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
| 122 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
| 123 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
| 124 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | neurology | 2019 | experimental therapy | Poland | 33 |
| 125 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2019 | experimental therapy | Poland | 40 |
| 126 | cord tissue (Wharton's jelly) | allo-unrelated | other vascular and retinal disorders | ophthalmology | 2019 | experimental therapy | Poland | 34 |
| 127 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2019 | experimental therapy | Poland | 71 |
| 128 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy; epilepsy; | neurology | 2019 | experimental therapy | Poland | 3 |
| 129 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 6 |
| 130 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development; epilepsia | neurology | 2019 | experimental therapy | Poland | 2 |
| 131 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 2 |
| 132 | cord tissue (Wharton's jelly) | allo-unrelated | birth asphyxia | neurology | 2019 | experimental therapy | Poland | 5 |
| 133 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2019 | experimental therapy | Poland | 10 |
| 134 | cord tissue (Wharton's jelly) | allo-unrelated | secondary progressive multiple sclerosis | neurology | 2019 | experimental therapy | Poland | 22 |
| 135 | cord tissue (Wharton's jelly) | allo-unrelated | condition after sympathetic inflammation of the left eye | ophthalmology | 2019 | experimental therapy | Poland | 23 |
| 136 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2019 | experimental therapy | Poland | 40 |
| 137 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar ataxia | neurology | 2019 | experimental therapy | Poland | 50 |
| 138 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia; developmental delay | neurology | 2019 | experimental therapy | Poland | 9 |
| 139 | cord tissue (Wharton's jelly) | allo-unrelated | Dandy-Walker malformation; trisomy 9 | neurology | 2019 | experimental therapy | Poland | 10 |
| 140 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2019 | experimental therapy | Poland | 10 |
| 141 | cord tissue (Wharton's jelly) | allo-related | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 4 |
| 142 | cord tissue (Wharton's jelly) | allo-unrelated | Asperger syndrome | neurology | 2019 | experimental therapy | Poland | 10 |
| 143 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2019 | experimental therapy | Poland | 62 |
| 144 | cord tissue (Wharton's jelly) | allo-unrelated | non-adhesion left tibia shank fracture; neurofibromatosis t. I | orthopedics | 2019 | experimental therapy | Poland | 18 |
| 145 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2019 | experimental therapy | Poland | 46 |
| 146 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 9 |
| 147 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2019 | experimental therapy | Poland | 5 |
| 148 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 3 |
| 149 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 7 |
| 150 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2019 | experimental therapy | Poland | 11 |
| 151 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2019 | experimental therapy | Poland | 5 |
| 152 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 3 |
| 153 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 70 |
| 154 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 11 |
| 155 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy; epilepsy; delayed psychomotor development | neurology | 2019 | experimental therapy | Poland | 13 |
| 156 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2019 | experimental therapy | Poland | 3 |
| 157 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 3 |
| 158 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2019 | experimental therapy | Poland | 3 |
| 159 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; Wolf-Hirschhorn syndrome | neurology | 2019 | experimental therapy | Poland | 10 |
| 160 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 61 |
| 161 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 38 |
| 162 | cord tissue (Wharton's jelly) | allo-unrelated | hypoxia-ischemic encephalopathy | neurology | 2019 | experimental therapy | Poland | 2 |
| 163 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2019 | experimental therapy | Poland | 7 |
| 164 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2019 | experimental therapy | Poland | 30 |
| 165 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 4 |
| 166 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 2 |
| 167 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
| 168 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2019 | clinical trial | Sweden | no data |
| 169 | cord tissue (Wharton's jelly) | allo-related | coxarthrosis | orthopedics | 2019 | experimental therapy | Poland | 57 |
| 170 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 35 |
| 171 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 23 |
| 172 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 26 |
| 173 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2019 | experimental therapy | Poland | 21 |
| 174 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 33 |
| 175 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 72 |
| 176 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2019 | experimental therapy | Poland | 35 |
| 177 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 68 |
| 178 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2019 | experimental therapy | Poland | 43 |
| 179 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2019 | experimental therapy | Poland | 38 |
| 180 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2019 | experimental therapy | Poland | 19 |
| 181 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2019 | experimental therapy | Poland | 26 |
| 182 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 60 |
| 183 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 65 |
| 184 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 58 |
| 185 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2019 | experimental therapy | Poland | 54 |
| 186 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2019 | experimental therapy | Poland | 5 |
| 187 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2019 | experimental therapy | Poland | 39 |
| 188 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 11 |
| 189 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 3 |
| 190 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida; epilepsy | neurology | 2019 | experimental therapy | Poland | 2 |
| 191 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 3 |
| 192 | cord tissue (Wharton's jelly) | allo-unrelated | microcephalia; cerebellar syndrome; delayed psychomotor development | neurology | 2019 | experimental therapy | Poland | 7 |
| 193 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia; encephalopathy | neurology | 2019 | experimental therapy | Poland | 8 |
| 194 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development; Chiari malformation | neurology | 2019 | experimental therapy | Poland | 4 |
| 195 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy; epilepsy | neurology | 2019 | experimental therapy | Poland | 17 |
| 196 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 0 |
| 197 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 9 |
| 198 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2019 | experimental therapy | Poland | 6 |
| 199 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 55 |
| 200 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | no data |
| 201 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | no data |
| 202 | cord tissue (Wharton's jelly) | allo-related | autism | neurology | 2018 | experimental therapy | Poland | 4 |
| 203 | cord tissue (Wharton's jelly) | allo-unrelated | autism, delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 6 |
| 204 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 52 |
| 205 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 42 |
| 206 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 36 |
| 207 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 60 |
| 208 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 9 |
| 209 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 210 | cord tissue (Wharton's jelly) | allo-unrelated | cartilage damage | orthopedics | 2018 | experimental therapy | Poland | 56 |
| 211 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system - syndrom Pierre-Robin | neurology | 2018 | experimental therapy | Poland | 2 |
| 212 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 4 |
| 213 | cord tissue (Wharton's jelly) | allo-unrelated | hydrocephalus; myelomeningocele | neurology | 2018 | experimental therapy | Poland | 2 |
| 214 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2018 | experimental therapy | Poland | 64 |
| 215 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
| 216 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 54 |
| 217 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
| 218 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development; epilepsia | neurology | 2018 | experimental therapy | Poland | 4 |
| 219 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
| 220 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 221 | cord tissue (Wharton's jelly) | allo-unrelated | genetic syndrome - deletion of part of chromosome 3 | neurology | 2018 | experimental therapy | Poland | 8 |
| 222 | cord tissue (Wharton's jelly) | allo-unrelated | general hypotonia; autism | neurology | 2018 | experimental therapy | Poland | 8 |
| 223 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
| 224 | cord tissue (Wharton's jelly) | allo-related | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 10 |
| 225 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 226 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 44 |
| 227 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 42 |
| 228 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 38 |
| 229 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 10 |
| 230 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 15 |
| 231 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2018 | experimental therapy | Poland | 5 |
| 232 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 54 |
| 233 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 56 |
| 234 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 53 |
| 235 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2018 | experimental therapy | Poland | 39 |
| 236 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 46 |
| 237 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 33 |
| 238 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 12 |
| 239 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
| 240 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2018 | experimental therapy | Poland | 34 |
| 241 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
| 242 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 3 |
| 243 | cord tissue (Wharton's jelly) | allo-unrelated | Leber's hereditary optic neuropathy | ophthalmology | 2018 | experimental therapy | Poland | 18 |
| 244 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2018 | experimental therapy | Poland | 18 |
| 245 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2018 | experimental therapy | Poland | 15 |
| 246 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 34 |
| 247 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2018 | experimental therapy | Poland | 4 |
| 248 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
| 249 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia; agenesis corporis callosi | neurology | 2018 | experimental therapy | Poland | 2 |
| 250 | cord tissue (Wharton's jelly) | allo-unrelated | congenital myasthenia | neurology | 2018 | experimental therapy | Poland | 3 |
| 251 | cord tissue (Wharton's jelly) | allo-unrelated | congenital myasthenia | neurology | 2018 | experimental therapy | Poland | 6 |
| 252 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2018 | experimental therapy | Poland | 7 |
| 253 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2018 | experimental therapy | Poland | 5 |
| 254 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 44 |
| 255 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 16 |
| 256 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system- Pitt Hopkins syndrome | neurology | 2018 | experimental therapy | Poland | 10 |
| 257 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 1 |
| 258 | cord tissue (Wharton's jelly) | allo-unrelated | myelomeningocele | neurology | 2018 | experimental therapy | Poland | 1 |
| 259 | cord tissue (Wharton's jelly) | allo-unrelated | multiple system atrophy | neurology | 2018 | experimental therapy | Poland | 61 |
| 260 | cord tissue (Wharton's jelly) | allo-unrelated | Friedreich's ataxia | neurology | 2018 | experimental therapy | Poland | 22 |
| 261 | cord tissue (Wharton's jelly) | allo-unrelated | neuropathy | neurology | 2018 | experimental therapy | Poland | 47 |
| 262 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 7 |
| 263 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 13 |
| 264 | cord tissue (Wharton's jelly) | allo-unrelated | progressive supranuclear atrophy | neurology | 2018 | experimental therapy | Poland | 62 |
| 265 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
| 266 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
| 267 | cord tissue (Wharton's jelly) | allo-unrelated | multiple system atrophy | neurology | 2018 | experimental therapy | Poland | 47 |
| 268 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 62 |
| 269 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 49 |
| 270 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 2 |
| 271 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
| 272 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 273 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 7 |
| 274 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 49 |
| 275 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
| 276 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 8 |
| 277 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 278 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 1 |
| 279 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 280 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
| 281 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 42 |
| 282 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 30 |
| 283 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 73 |
| 284 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 66 |
| 285 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
| 286 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 30 |
| 287 | cord tissue (Wharton's jelly) | allo-unrelated | paralysis | neurology | 2018 | experimental therapy | Poland | 9 |
| 288 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 2 |
| 289 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
| 290 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 50 |
| 291 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2018 | experimental therapy | Poland | 22 |
| 292 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 38 |
| 293 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis | orthopedics | 2018 | experimental therapy | Poland | 32 |
| 294 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
| 295 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
| 296 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
| 297 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 298 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 9 |
| 299 | cord tissue (Wharton's jelly) | allo-related | autism; congenital cytomegaly | neurology | 2018 | experimental therapy | Poland | 6 |
| 300 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
| 301 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 9 |
| 302 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 303 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 48 |
| 304 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 41 |
| 305 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 40 |
| 306 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 7 |
| 307 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 78 |
| 308 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 60 |
| 309 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 3 |
| 310 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 61 |
| 311 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 312 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome; delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 3 |
| 313 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 1 |
| 314 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 13 |
| 315 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
| 316 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 15 |
| 317 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 2 |
| 318 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 1 |
| 319 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 4 |
| 320 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 42 |
| 321 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 322 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 323 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 43 |
| 324 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 62 |
| 325 | cord tissue (Wharton's jelly) | allo-unrelated | bilateral edema of the optic nerves | ophthalmology | 2018 | experimental therapy | Poland | 12 |
| 326 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 4 |
| 327 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
| 328 | cord tissue (Wharton's jelly) | allo-unrelated | Phelan-McDermid Syndrome | neurology | 2018 | experimental therapy | Poland | 17 |
| 329 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2018 | experimental therapy | Poland | 24 |
| 330 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 8 |
| 331 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | below 1 |
| 332 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
| 333 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 1 |
| 334 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 12 |
| 335 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 70 |
| 336 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 18 |
| 337 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 51 |
| 338 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; encephalopathy | neurology | 2018 | experimental therapy | Poland | 1 |
| 339 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 8 |
| 340 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 78 |
| 341 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 68 |
| 342 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 7 |
| 343 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 4 |
| 344 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 26 |
| 345 | cord tissue (Wharton's jelly) | allo-unrelated | general hypotonia | neurology | 2018 | experimental therapy | Poland | 7 |
| 346 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
| 347 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 348 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 1 |
| 349 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 64 |
| 350 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 7 |
| 351 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2018 | experimental therapy | Poland | 82 |
| 352 | cord tissue (Wharton's jelly) | allo-unrelated | visual pathway dysfunction | ophthalmology | 2018 | experimental therapy | Poland | 48 |
| 353 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 21 |
| 354 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 71 |
| 355 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 69 |
| 356 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 22 |
| 357 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
| 358 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
| 359 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 11 |
| 360 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 58 |
| 361 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 56 |
| 362 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2018 | experimental therapy | Poland | 11 |
| 363 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | neurology | 2018 | experimental therapy | Poland | 12 |
| 364 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 64 |
| 365 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
| 366 | cord tissue (Wharton's jelly) | allo-unrelated | general hypotonia | neurology | 2018 | experimental therapy | Poland | 9 |
| 367 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy; developmental delay | neurology | 2018 | experimental therapy | Poland | 8 |
| 368 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 7 |
| 369 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 7 |
| 370 | cord tissue (Wharton's jelly) | allo-unrelated | degeneration of the cartilage of the knee joint | orthopedics | 2018 | experimental therapy | Poland | 57 |
| 371 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 1 |
| 372 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 66 |
| 373 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 70 |
| 374 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
| 375 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
| 376 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 1 |
| 377 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 61 |
| 378 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 37 |
| 379 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 50 |
| 380 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 23 |
| 381 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 69 |
| 382 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 18 |
| 383 | cord tissue (Wharton's jelly) | allo-unrelated | brain disorder, unspecified | neurology | 2018 | experimental therapy | Poland | 10 |
| 384 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 85 |
| 385 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 2 |
| 386 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 387 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 388 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 1 |
| 389 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 38 |
| 390 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
| 391 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
| 392 | cord tissue (Wharton's jelly) | allo-unrelated | Wolf-Hirschhorn syndrome | neurology | 2018 | experimental therapy | Poland | 1 |
| 393 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy; epilepsy | neurology | 2018 | experimental therapy | Poland | 21 |
| 394 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
| 395 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | below 1 |
| 396 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 6 |
| 397 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 38 |
| 398 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 64 |
| 399 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 29 |
| 400 | cord tissue (Wharton's jelly) | allo-unrelated | state after encephalitis; epilepsy | neurology | 2018 | experimental therapy | Poland | 44 |
| 401 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 42 |
| 402 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 44 |
| 403 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 47 |
| 404 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 27 |
| 405 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
| 406 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 407 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
| 408 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
| 409 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 410 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 48 |
| 411 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 55 |
| 412 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 16 |
| 413 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
| 414 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 6 |
| 415 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
| 416 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 5 |
| 417 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 4 |
| 418 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
| 419 | cord tissue (Wharton's jelly) | allo-unrelated | general hypotonia | neurology | 2018 | experimental therapy | Poland | 2 |
| 420 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 48 |
| 421 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 422 | cord tissue (Wharton's jelly) | allo-unrelated | microcephalia | neurology | 2018 | experimental therapy | Poland | 12 |
| 423 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 67 |
| 424 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 5 |
| 425 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 55 |
| 426 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 34 |
| 427 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 428 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 429 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 11 |
| 430 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 431 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 66 |
| 432 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
| 433 | cord tissue (Wharton's jelly) | allo-unrelated | lack of expected normal physical development, unspecified | neurology | 2018 | experimental therapy | Poland | 10 |
| 434 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
| 435 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
| 436 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
| 437 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
| 438 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
| 439 | cord tissue (Wharton's jelly) | allo-unrelated | diabetes mellitus t. 1 | endocrinology | 2018 | clinical trial | Sweden | no data |
| 440 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 62 |
| 441 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 28 |
| 442 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 5 |
| 443 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 16 |
| 444 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development; atrophy of the optic nerves | neurology | 2018 | experimental therapy | Poland | 2 |
| 445 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 11 |
| 446 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 7 |
| 447 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 13 |
| 448 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
| 449 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 25 |
| 450 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 64 |
| 451 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 67 |
| 452 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 47 |
| 453 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 39 |
| 454 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 5 |
| 455 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 63 |
| 456 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 64 |
| 457 | cord tissue (Wharton's jelly) | allo-unrelated | arthrogryposis multiplex congenita; epilepsia | neurology | 2018 | experimental therapy | Poland | 6 |
| 458 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
| 459 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 49 |
| 460 | cord tissue (Wharton's jelly) | allo-unrelated | other reduction deformities of brain; schizencephaly | neurology | 2018 | experimental therapy | Poland | 5 |
| 461 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 462 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 53 |
| 463 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 44 |
| 464 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 38 |
| 465 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 62 |
| 466 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 67 |
| 467 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2018 | experimental therapy | Poland | 6 |
| 468 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 469 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 13 |
| 470 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy; cerebral palsy | neurology | 2018 | experimental therapy | Poland | 22 |
| 471 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 4 |
| 472 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 75 |
| 473 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2018 | experimental therapy | Poland | no data |
| 474 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 66 |
| 475 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 47 |
| 476 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 64 |
| 477 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 10 |
| 478 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 1 |
| 479 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 9 |
| 480 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 70 |
| 481 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 40 |
| 482 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 31 |
| 483 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 60 |
| 484 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 65 |
| 485 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 65 |
| 486 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 22 |
| 487 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2018 | experimental therapy | Poland | 8 |
| 488 | cord tissue (Wharton's jelly) | allo-unrelated | holoprosencephalia | neurology | 2018 | experimental therapy | Poland | 12 |
| 489 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 25 |
| 490 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 80 |
| 491 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 35 |
| 492 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 54 |
| 493 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 76 |
| 494 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 9 |
| 495 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 496 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 80 |
| 497 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia myotonica | neurology | 2018 | experimental therapy | Poland | 27 |
| 498 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4 |
| 499 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 75 |
| 500 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2018 | experimental therapy | Poland | 34 |
| 501 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 20 |
| 502 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 61 |
| 503 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 28 |
| 504 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 45 |
| 505 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 57 |
| 506 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 57 |
| 507 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 83 |
| 508 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 35 |
| 509 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 41 |
| 510 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 67 |
| 511 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2018 | experimental therapy | Poland | 7 |
| 512 | cord tissue (Wharton's jelly) | allo-unrelated | damage to the intercondylar fissure of the right knee | orthopedics | 2018 | experimental therapy | Poland | 40 |
| 513 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 54 |
| 514 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2018 | experimental therapy | Poland | 54 |
| 515 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 6 |
| 516 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
| 517 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2 |
| 518 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 9 |
| 519 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2018 | experimental therapy | Poland | 7 |
| 520 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 40 |
| 521 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 21 |
| 522 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 62 |
| 523 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2018 | experimental therapy | Poland | 8 |
| 524 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 525 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 28 |
| 526 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 52 |
| 527 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 47 |
| 528 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 46 |
| 529 | cord tissue (Wharton's jelly) | allo-unrelated | Friedreich's ataxia | neurology | 2018 | experimental therapy | Poland | 31 |
| 530 | cord tissue (Wharton's jelly) | allo-unrelated | Friedreich's ataxia | neurology | 2018 | experimental therapy | Poland | 27 |
| 531 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2018 | experimental therapy | Poland | 70 |
| 532 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 9 |
| 533 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 55 |
| 534 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2018 | experimental therapy | Poland | 20 |
| 535 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 34 |
| 536 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 44 |
| 537 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 30 |
| 538 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2018 | experimental therapy | Poland | 46 |
| 539 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2018 | experimental therapy | Poland | 20 |
| 540 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 65 |
| 541 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 30 |
| 542 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 38 |
| 543 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 46 |
| 544 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2018 | experimental therapy | Poland | 14 |
| 545 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 38 |
| 546 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 51 |
| 547 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 50 |
| 548 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 59 |
| 549 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 47 |
| 550 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 66 |
| 551 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 52 |
| 552 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 33 |
| 553 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 3 |
| 554 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 27 |
| 555 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 34 |
| 556 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 36 |
| 557 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 55 |
| 558 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 39 |
| 559 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 46 |
| 560 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 32 |
| 561 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 41 |
| 562 | cord tissue (Wharton's jelly) | allo-unrelated | degeneration of the cartilage of the knee joint | orthopedics | 2018 | experimental therapy | Poland | 34 |
| 563 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 1 |
| 564 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 67 |
| 565 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 66 |
| 566 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 28 |
| 567 | cord tissue (Wharton's jelly) | allo-unrelated | myopathy | neurology | 2018 | experimental therapy | Poland | 57 |
| 568 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2018 | experimental therapy | Poland | 2 |
| 569 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 52 |
| 570 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 44 |
| 571 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 48 |
| 572 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 59 |
| 573 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2018 | experimental therapy | Poland | 3 |
| 574 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 44 |
| 575 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 16 |
| 576 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 61 |
| 577 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 36 |
| 578 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 25 |
| 579 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 31 |
| 580 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 68 |
| 581 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 71 |
| 582 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 57 |
| 583 | cord tissue (Wharton's jelly) | allo-unrelated | anterior ischemic optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 67 |
| 584 | cord tissue (Wharton's jelly) | allo-unrelated | moyamoya disease | neurology | 2017 | experimental therapy | Poland | 17 |
| 585 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | below 1 |
| 586 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 7 |
| 587 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
| 588 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
| 589 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 48 |
| 590 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 14 |
| 591 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 15 |
| 592 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 8 |
| 593 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 48 |
| 594 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 66 |
| 595 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 7 |
| 596 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1 |
| 597 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 7 |
| 598 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
| 599 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 45 |
| 600 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 36 |
| 601 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 33 |
| 602 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 7 |
| 603 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8 |
| 604 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2017 | experimental therapy | Poland | 2 |
| 605 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 54 |
| 606 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 6 |
| 607 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
| 608 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 46 |
| 609 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 59 |
| 610 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 43 |
| 611 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 37 |
| 612 | cord tissue (Wharton's jelly) | allo-unrelated | cartilage damage | orthopedics | 2017 | experimental therapy | Poland | 46 |
| 613 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 64 |
| 614 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 69 |
| 615 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 5 |
| 616 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
| 617 | cord tissue (Wharton's jelly) | allo-unrelated | autism; encephalopathy | neurology | 2017 | experimental therapy | Poland | 7 |
| 618 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2017 | experimental therapy | Poland | 2 |
| 619 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 52 |
| 620 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
| 621 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 17 |
| 622 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 10 |
| 623 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 65 |
| 624 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 61 |
| 625 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 78 |
| 626 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 29 |
| 627 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 24 |
| 628 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
| 629 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 10 |
| 630 | cord tissue (Wharton's jelly) | allo-unrelated | congenital malformations of the nervous system, unspecified | neurology | 2017 | experimental therapy | Poland | 8 |
| 631 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 60 |
| 632 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 35 |
| 633 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 52 |
| 634 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 8 |
| 635 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1 |
| 636 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 28 |
| 637 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 60 |
| 638 | cord tissue (Wharton's jelly) | allo-unrelated | other specific disorders of the central nervous system | neurology | 2017 | experimental therapy | Poland | 2 |
| 639 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 85 |
| 640 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2017 | experimental therapy | Poland | 66 |
| 641 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 12 |
| 642 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8 |
| 643 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 14 |
| 644 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 38 |
| 645 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 24 |
| 646 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 11 |
| 647 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
| 648 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury; tetraparesis | orthopedics | 2017 | experimental therapy | Poland | 42 |
| 649 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 5 |
| 650 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica; epilepsia | neurology | 2017 | experimental therapy | Poland | 2 |
| 651 | cord tissue (Wharton's jelly) | allo-unrelated | hypoxia-ischemic encephalopathy | neurology | 2017 | experimental therapy | Poland | 1 |
| 652 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2017 | experimental therapy | Poland | 65 |
| 653 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 61 |
| 654 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 12 |
| 655 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 3 |
| 656 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 37 |
| 657 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 78 |
| 658 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 44 |
| 659 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 22 |
| 660 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1 |
| 661 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
| 662 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 32 |
| 663 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2017 | experimental therapy | Poland | 1 |
| 664 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 10 |
| 665 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
| 666 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 7 |
| 667 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 18 |
| 668 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development; epilepsia | neurology | 2017 | experimental therapy | Poland | 11 |
| 669 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 9 |
| 670 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 22 |
| 671 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 43 |
| 672 | cord tissue (Wharton's jelly) | allo-unrelated | condition after myelitis | neurology | 2017 | experimental therapy | Poland | 34 |
| 673 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 33 |
| 674 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 78 |
| 675 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 30 |
| 676 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 77 |
| 677 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 54 |
| 678 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 2 |
| 679 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 65 |
| 680 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 47 |
| 681 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
| 682 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
| 683 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 27 |
| 684 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
| 685 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
| 686 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
| 687 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | no data |
| 688 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 53 |
| 689 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 55 |
| 690 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
| 691 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 13 |
| 692 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2017 | experimental therapy | Poland | 3 |
| 693 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 15 |
| 694 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
| 695 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 9 |
| 696 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 8 |
| 697 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis | orthopedics | 2017 | experimental therapy | Poland | 27 |
| 698 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | no data |
| 699 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 16 |
| 700 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2017 | experimental therapy | Poland | 35 |
| 701 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2017 | experimental therapy | Poland | 7 |
| 702 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 53 |
| 703 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 46 |
| 704 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 59 |
| 705 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 57 |
| 706 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 62 |
| 707 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 63 |
| 708 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 4 |
| 709 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
| 710 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
| 711 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 58 |
| 712 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 25 |
| 713 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 38 |
| 714 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 56 |
| 715 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 10 |
| 716 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 4 |
| 717 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 2 |
| 718 | cord tissue (Wharton's jelly) | allo-unrelated | global developmental delay | neurology | 2017 | experimental therapy | Poland | 7 |
| 719 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 60 |
| 720 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 49 |
| 721 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 59 |
| 722 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 68 |
| 723 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2 |
| 724 | cord tissue (Wharton's jelly) | allo-unrelated | myopathy of congenital fiber type disproportion; damage to the central nervous system | neurology | 2017 | experimental therapy | Poland | 2 |
| 725 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia, autism | neurology | 2017 | experimental therapy | Poland | 6 |
| 726 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
| 727 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 6 |
| 728 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 31 |
| 729 | cord tissue (Wharton's jelly) | allo-unrelated | Devic’s disease | neurology | 2017 | experimental therapy | Poland | 45 |
| 730 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
| 731 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
| 732 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
| 733 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
| 734 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
| 735 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 7 |
| 736 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 13 |
| 737 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 10 |
| 738 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 18 |
| 739 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 26 |
| 740 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 12 |
| 741 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51 |
| 742 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 5 |
| 743 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 15 |
| 744 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8 |
| 745 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2017 | experimental therapy | Poland | 5 |
| 746 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 65 |
| 747 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 70 |
| 748 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51 |
| 749 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 64 |
| 750 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 74 |
| 751 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 43 |
| 752 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
| 753 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /BMD | neurology | 2017 | experimental therapy | Poland | 23 |
| 754 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 76 |
| 755 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 63 |
| 756 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia myotonica | neurology | 2017 | experimental therapy | Poland | 3 |
| 757 | cord tissue (Wharton's jelly) | allo-unrelated | arthrogryposis multiplex congenita | neurology | 2017 | experimental therapy | Poland | 3 |
| 758 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 7 |
| 759 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 2 |
| 760 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 3 |
| 761 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8 |
| 762 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 4 |
| 763 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 39 |
| 764 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 30 |
| 765 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 2 |
| 766 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 42 |
| 767 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 33 |
| 768 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 3 |
| 769 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 4 |
| 770 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 56 |
| 771 | cord tissue (Wharton's jelly) | allo-unrelated | global developmental delay | neurology | 2017 | experimental therapy | Poland | 4 |
| 772 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia myotonica | neurology | 2017 | experimental therapy | Poland | 41 |
| 773 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 54 |
| 774 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 46 |
| 775 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 32 |
| 776 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 6 |
| 777 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 13 |
| 778 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 7 |
| 779 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy; cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1 |
| 780 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 6 |
| 781 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 1 |
| 782 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 35 |
| 783 | cord tissue (Wharton's jelly) | allo-unrelated | condition after encephalitis | neurology | 2017 | experimental therapy | Poland | 19 |
| 784 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 49 |
| 785 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 46 |
| 786 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 6 |
| 787 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 6 |
| 788 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 4 |
| 789 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6 |
| 790 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 60 |
| 791 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 62 |
| 792 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 48 |
| 793 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 31 |
| 794 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 45 |
| 795 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51 |
| 796 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 24 |
| 797 | cord tissue (Wharton's jelly) | allo-unrelated | Krabbe disease | neurology | 2017 | experimental therapy | Poland | 6 |
| 798 | cord tissue (Wharton's jelly) | allo-unrelated | hypoxia-ischemic encephalopathy | neurology | 2017 | experimental therapy | Poland | 1 |
| 799 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 5 |
| 800 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3 |
| 801 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
| 802 | cord tissue (Wharton's jelly) | allo-related | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 12 |
| 803 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5 |
| 804 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 33 |
| 805 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 10 |
| 806 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 31 |
| 807 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 31 |
| 808 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 35 |
| 809 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 63 |
| 810 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 36 |
| 811 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 77 |
| 812 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
| 813 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 35 |
| 814 | cord tissue (Wharton's jelly) | allo-unrelated | ischemia within the optic nerve | ophthalmology | 2017 | experimental therapy | Poland | 37 |
| 815 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 66 |
| 816 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 11 |
| 817 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 13 |
| 818 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 52 |
| 819 | cord tissue (Wharton's jelly) | allo-unrelated | syndrom IFAP | hematology | 2017 | experimental therapy | Poland | 3 |
| 820 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 6 |
| 821 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 3 |
| 822 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 7 |
| 823 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 6 |
| 824 | cord tissue (Wharton's jelly) | allo-unrelated | hydrocephalus; neonatal cerebral leukomalacia | neurology | 2017 | experimental therapy | Poland | 2 |
| 825 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 31 |
| 826 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 34 |
| 827 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 45 |
| 828 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 27 |
| 829 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 52 |
| 830 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 31 |
| 831 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 37 |
| 832 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 24 |
| 833 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 69 |
| 834 | cord tissue (Wharton's jelly) | allo-unrelated | no bone adhesion | orthopedics | 2017 | experimental therapy | Poland | 17 |
| 835 | cord tissue (Wharton's jelly) | allo-unrelated | no bone adhesion | orthopedics | 2017 | experimental therapy | Poland | 14 |
| 836 | cord tissue (Wharton's jelly) | allo-unrelated | traumatic brain injury | neurology | 2017 | experimental therapy | Poland | 9 |
| 837 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 15 |
| 838 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 6 |
| 839 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; epilepsy | neurology | 2017 | experimental therapy | Poland | 5 |
| 840 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy; cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4 |
| 841 | cord tissue (Wharton's jelly) | allo-unrelated | arthrogryposis multiplex congenita | neurology | 2017 | experimental therapy | Poland | 1 |
| 842 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 37 |
| 843 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2017 | experimental therapy | Poland | 1 |
| 844 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 48 |
| 845 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 40 |
| 846 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 61 |
| 847 | cord tissue (Wharton's jelly) | allo-unrelated | chronic myeloid leukemia | hematology | 2017 | experimental therapy | Poland | 5 |
| 848 | cord tissue (Wharton's jelly) | allo-unrelated | congenital fiber-type disproportion myopathy | neurology | 2017 | experimental therapy | Poland | 1 |
| 849 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 11 |
| 850 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 9 |
| 851 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 26 |
| 852 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 11 |
| 853 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy; neonatal cerebral leukomalacia | neurology | 2017 | experimental therapy | Poland | 1 |
| 854 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 52 |
| 855 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 41 |
| 856 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2017 | experimental therapy | Poland | 5 |
| 857 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2017 | experimental therapy | Poland | 21 |
| 858 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 13 |
| 859 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 56 |
| 860 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 38 |
| 861 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 47 |
| 862 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 64 |
| 863 | cord tissue (Wharton's jelly) | allo-unrelated | syringomielia | neurology | 2017 | experimental therapy | Poland | 42 |
| 864 | cord tissue (Wharton's jelly) | allo-unrelated | transverse myelitis | neurology | 2017 | experimental therapy | Poland | 8 |
| 865 | cord tissue (Wharton's jelly) | allo-unrelated | cranium bifidum | neurology | 2017 | experimental therapy | Poland | 5 |
| 866 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2017 | experimental therapy | Poland | 3 |
| 867 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 28 |
| 868 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 22 |
| 869 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 59 |
| 870 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 18 |
| 871 | cord tissue (Wharton's jelly) | allo-unrelated | cri du chat syndrome | neurology | 2017 | experimental therapy | Poland | 8 |
| 872 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2017 | experimental therapy | Poland | 58 |
| 873 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 8 |
| 874 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 12 |
| 875 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 30 |
| 876 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 42 |
| 877 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 39 |
| 878 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51 |
| 879 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 39 |
| 880 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 43 |
| 881 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 23 |
| 882 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 75 |
| 883 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 25 |
| 884 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 41 |
| 885 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 44 |
| 886 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 28 |
| 887 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 45 |
| 888 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 65 |
| 889 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 56 |
| 890 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 30 |
| 891 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 10 |
| 892 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 24 |
| 893 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | neurology | 2017 | experimental therapy | Poland | 29 |
| 894 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2017 | experimental therapy | Poland | 33 |
| 895 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 31 |
| 896 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2017 | experimental therapy | Poland | 23 |
| 897 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 52 |
| 898 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 34 |
| 899 | cord tissue (Wharton's jelly) | allo-unrelated | cartilage damage | orthopedics | 2017 | experimental therapy | Poland | 61 |
| 900 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 46 |
| 901 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 48 |
| 902 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 56 |
| 903 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 26 |
| 904 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia myotonica | neurology | 2017 | experimental therapy | Poland | 37 |
| 905 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 37 |
| 906 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 49 |
| 907 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 58 |
| 908 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 34 |
| 909 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 44 |
| 910 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 47 |
| 911 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2017 | experimental therapy | Poland | 7 |
| 912 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | no data |
| 913 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 71 |
| 914 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 37 |
| 915 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 67 |
| 916 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
| 917 | cord tissue (Wharton's jelly) | allo-unrelated | premature ovarian failure | ginecology | 2016 | experimental therapy | Poland | 34 |
| 918 | cord tissue (Wharton's jelly) | allo-unrelated | premature ovarian failure | ginecology | 2016 | experimental therapy | Poland | 23 |
| 919 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60 |
| 920 | cord tissue (Wharton's jelly) | allo-unrelated | meniscus damage | orthopedics | 2016 | experimental therapy | Poland | 35 |
| 921 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 44 |
| 922 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 38 |
| 923 | cord tissue (Wharton's jelly) | allo-unrelated | endometrial atrophy | ginecology | 2016 | experimental therapy | Poland | 39 |
| 924 | cord tissue (Wharton's jelly) | allo-unrelated | endometrial atrophy | ginecology | 2016 | experimental therapy | Poland | 37 |
| 925 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 33 |
| 926 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 31 |
| 927 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 15 |
| 928 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /BMD | neurology | 2016 | experimental therapy | Poland | 19 |
| 929 | cord tissue (Wharton's jelly) | allo-unrelated | degeneration of the cartilage of the knee joint | orthopedics | 2016 | experimental therapy | Poland | 54 |
| 930 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 44 |
| 931 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
| 932 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis | orthopedics | 2016 | experimental therapy | Poland | 27 |
| 933 | cord tissue (Wharton's jelly) | allo-unrelated | neurodevelopmental disorders | neurology | 2016 | experimental therapy | Poland | 4 |
| 934 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar syndrome | neurology | 2016 | experimental therapy | Poland | 28 |
| 935 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 4 |
| 936 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 4 |
| 937 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 10 |
| 938 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 44 |
| 939 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 4 |
| 940 | cord tissue (Wharton's jelly) | allo-unrelated | cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 57 |
| 941 | cord tissue (Wharton's jelly) | allo-unrelated | injuries to the spinal nerves | neurology | 2016 | experimental therapy | Poland | below 1 |
| 942 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 17 |
| 943 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 3 |
| 944 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 16 |
| 945 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2016 | experimental therapy | Poland | 33 |
| 946 | cord tissue (Wharton's jelly) | allo-unrelated | myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy | ophthalmology | 2016 | experimental therapy | Poland | 37 |
| 947 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2016 | experimental therapy | Poland | 37 |
| 948 | cord tissue (Wharton's jelly) | allo-unrelated | diffuse cartilage damage left medial compartment of the knee | orthopedics | 2016 | experimental therapy | Poland | 50 |
| 949 | cord tissue (Wharton's jelly) | allo-unrelated | polineuropathy | neurology | 2016 | experimental therapy | Poland | 70 |
| 950 | cord tissue (Wharton's jelly) | allo-unrelated | epileptic encephalopathy | neurology | 2016 | experimental therapy | Poland | 3 |
| 951 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 14 |
| 952 | cord tissue (Wharton's jelly) | allo-unrelated | gangliosidosis t. 1 | neurology | 2016 | experimental therapy | Poland | 1 |
| 953 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | no data |
| 954 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
| 955 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56 |
| 956 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 48 |
| 957 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 4 |
| 958 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 18 |
| 959 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 2 |
| 960 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56 |
| 961 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 72 |
| 962 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 41 |
| 963 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
| 964 | cord tissue (Wharton's jelly) | allo-unrelated | chondronecrosis femoral condyle | orthopedics | 2016 | experimental therapy | Poland | 54 |
| 965 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 68 |
| 966 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 58 |
| 967 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 13 |
| 968 | cord tissue (Wharton's jelly) | allo-unrelated | fetal alcohol spectrum disorders | neurology | 2016 | experimental therapy | Poland | 5 |
| 969 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 20 |
| 970 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49 |
| 971 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 51 |
| 972 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 41 |
| 973 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
| 974 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 16 |
| 975 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 10 |
| 976 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 6 |
| 977 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 15 |
| 978 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
| 979 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2016 | experimental therapy | Poland | 24 |
| 980 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 9 |
| 981 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 44 |
| 982 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2016 | experimental therapy | Poland | below 1 |
| 983 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 68 |
| 984 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 29 |
| 985 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 1 |
| 986 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 7 |
| 987 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 1 |
| 988 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 60 |
| 989 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 71 |
| 990 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 52 |
| 991 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 65 |
| 992 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 32 |
| 993 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 34 |
| 994 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 24 |
| 995 | cord tissue (Wharton's jelly) | allo-unrelated | patella cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 53 |
| 996 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2016 | experimental therapy | Poland | 20 |
| 997 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 59 |
| 998 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | no data |
| 999 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2016 | experimental therapy | Poland | 4 |
| 1000 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 2 |
| 1001 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2016 | experimental therapy | Poland | 3 |
| 1002 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10 |
| 1003 | cord tissue (Wharton's jelly) | allo-unrelated | patella cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 60 |
| 1004 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53 |
| 1005 | cord tissue (Wharton's jelly) | allo-unrelated | no data | ophthalmology | 2016 | experimental therapy | Poland | 66 |
| 1006 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 31 |
| 1007 | cord tissue (Wharton's jelly) | allo-unrelated | ataxia hereditaria | neurology | 2016 | experimental therapy | Poland | 69 |
| 1008 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 31 |
| 1009 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 37 |
| 1010 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 17 |
| 1011 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 30 |
| 1012 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 34 |
| 1013 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 59 |
| 1014 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 3 |
| 1015 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2016 | experimental therapy | Poland | 2 |
| 1016 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 1 |
| 1017 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 12 |
| 1018 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 12 |
| 1019 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 5 |
| 1020 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2 |
| 1021 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 13 |
| 1022 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 68 |
| 1023 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 54 |
| 1024 | cord tissue (Wharton's jelly) | allo-unrelated | age-related macular degeneration | ophthalmology | 2016 | experimental therapy | Poland | 86 |
| 1025 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 23 |
| 1026 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
| 1027 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49 |
| 1028 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 47 |
| 1029 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 14 |
| 1030 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 54 |
| 1031 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2016 | experimental therapy | Poland | 79 |
| 1032 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 3 |
| 1033 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 8 |
| 1034 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 38 |
| 1035 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2016 | experimental therapy | Poland | 66 |
| 1036 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 7 |
| 1037 | cord tissue (Wharton's jelly) | allo-unrelated | developmental delay | neurology | 2016 | experimental therapy | Poland | 7 |
| 1038 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 13 |
| 1039 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 39 |
| 1040 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
| 1041 | cord tissue (Wharton's jelly) | allo-unrelated | global developmental delay | neurology | 2016 | experimental therapy | Poland | 6 |
| 1042 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 9 |
| 1043 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 3 |
| 1044 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 1 |
| 1045 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2016 | experimental therapy | Poland | 4 |
| 1046 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 58 |
| 1047 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
| 1048 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49 |
| 1049 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
| 1050 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
| 1051 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 12 |
| 1052 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 58 |
| 1053 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 62 |
| 1054 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
| 1055 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 14 |
| 1056 | cord tissue (Wharton's jelly) | allo-unrelated | limb-girdle muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 22 |
| 1057 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 50 |
| 1058 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 54 |
| 1059 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy | neurology | 2016 | experimental therapy | Poland | 9 |
| 1060 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy | neurology | 2016 | experimental therapy | Poland | 6 |
| 1061 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 48 |
| 1062 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 72 |
| 1063 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 79 |
| 1064 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
| 1065 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 45 |
| 1066 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 61 |
| 1067 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 3 |
| 1068 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 32 |
| 1069 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 48 |
| 1070 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
| 1071 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2016 | experimental therapy | Poland | 2 |
| 1072 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 73 |
| 1073 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60 |
| 1074 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 7 |
| 1075 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 63 |
| 1076 | cord tissue (Wharton's jelly) | allo-unrelated | choroideremia | ophthalmology | 2016 | experimental therapy | Poland | 50 |
| 1077 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 49 |
| 1078 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 41 |
| 1079 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 33 |
| 1080 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 54 |
| 1081 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 55 |
| 1082 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 4 |
| 1083 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2 |
| 1084 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 51 |
| 1085 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56 |
| 1086 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 62 |
| 1087 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2016 | experimental therapy | Poland | 2 |
| 1088 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
| 1089 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 38 |
| 1090 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 64 |
| 1091 | cord tissue (Wharton's jelly) | allo-unrelated | malformation syndrome | neurology | 2016 | experimental therapy | Poland | 3 |
| 1092 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 64 |
| 1093 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
| 1094 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56 |
| 1095 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 54 |
| 1096 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 72 |
| 1097 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 46 |
| 1098 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
| 1099 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49 |
| 1100 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
| 1101 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59 |
| 1102 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 36 |
| 1103 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53 |
| 1104 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 45 |
| 1105 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 13 |
| 1106 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2016 | experimental therapy | Poland | 69 |
| 1107 | cord tissue (Wharton's jelly) | allo-unrelated | optic atrophy | ophthalmology | 2016 | experimental therapy | Poland | 69 |
| 1108 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 49 |
| 1109 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 9 |
| 1110 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 11 |
| 1111 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
| 1112 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 60 |
| 1113 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 42 |
| 1114 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 14 |
| 1115 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis | orthopedics | 2016 | experimental therapy | Poland | 27 |
| 1116 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66 |
| 1117 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59 |
| 1118 | cord tissue (Wharton's jelly) | allo-unrelated | epilepsia | neurology | 2016 | experimental therapy | Poland | 19 |
| 1119 | cord tissue (Wharton's jelly) | allo-unrelated | traumatic brain injury | neurology | 2016 | experimental therapy | Poland | 54 |
| 1120 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2 |
| 1121 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 18 |
| 1122 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 47 |
| 1123 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 69 |
| 1124 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 34 |
| 1125 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60 |
| 1126 | cord tissue (Wharton's jelly) | allo-unrelated | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 28 |
| 1127 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59 |
| 1128 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 52 |
| 1129 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61 |
| 1130 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 58 |
| 1131 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
| 1132 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2016 | experimental therapy | Poland | 19 |
| 1133 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 58 |
| 1134 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 46 |
| 1135 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53 |
| 1136 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 54 |
| 1137 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 63 |
| 1138 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 10 |
| 1139 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 25 |
| 1140 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 44 |
| 1141 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
| 1142 | cord tissue (Wharton's jelly) | allo-unrelated | patella cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 60 |
| 1143 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 39 |
| 1144 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 8 |
| 1145 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 25 |
| 1146 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 24 |
| 1147 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 20 |
| 1148 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 33 |
| 1149 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 69 |
| 1150 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 28 |
| 1151 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 7 |
| 1152 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 39 |
| 1153 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 37 |
| 1154 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 33 |
| 1155 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 29 |
| 1156 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 8 |
| 1157 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10 |
| 1158 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 22 |
| 1159 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 33 |
| 1160 | cord tissue (Wharton's jelly) | allo-unrelated | Stargardt's disease | ophthalmology | 2016 | experimental therapy | Poland | 53 |
| 1161 | cord tissue (Wharton's jelly) | allo-unrelated | atrophy of the optic nerves | ophthalmology | 2016 | experimental therapy | Poland | 20 |
| 1162 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 9 |
| 1163 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 12 |
| 1164 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2 |
| 1165 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 6 |
| 1166 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59 |
| 1167 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2016 | experimental therapy | Poland | 2 |
| 1168 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 65 |
| 1169 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 6 |
| 1170 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 14 |
| 1171 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2016 | experimental therapy | Poland | 3 |
| 1172 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 12 |
| 1173 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53 |
| 1174 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 35 |
| 1175 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10 |
| 1176 | cord tissue (Wharton's jelly) | allo-unrelated | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 48 |
| 1177 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2016 | experimental therapy | Poland | 18 |
| 1178 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 62 |
| 1179 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 64 |
| 1180 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 32 |
| 1181 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60 |
| 1182 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 44 |
| 1183 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10 |
| 1184 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy; encephalopathy | neurology | 2015 | experimental therapy | Poland | 8 |
| 1185 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | encephalopathy | neurology | 2015 | experimental therapy | Poland | 11 |
| 1186 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 26 |
| 1187 | cord tissue (Wharton's jelly) | allo-unrelated | retinitis pigmentosa | ophthalmology | 2015 | experimental therapy | Poland | 34 |
| 1188 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 16 |
| 1189 | cord tissue (Wharton's jelly) | allo-unrelated | anterior ischemic optic neuropathy | ophthalmology | 2015 | experimental therapy | Poland | 54 |
| 1190 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 14 |
| 1191 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 1 |
| 1192 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 34 |
| 1193 | cord tissue (Wharton's jelly) | allo-unrelated | leukodystrophy | neurology | 2015 | experimental therapy | Poland | 18 |
| 1194 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2015 | experimental therapy | Poland | 65 |
| 1195 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 24 |
| 1196 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2015 | experimental therapy | Poland | 54 |
| 1197 | cord tissue (Wharton's jelly) | allo-unrelated | intracranial injury | neurology | 2015 | experimental therapy | Poland | 24 |
| 1198 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 54 |
| 1199 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
| 1200 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 13 |
| 1201 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 9 |
| 1202 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 21 |
| 1203 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 48 |
| 1204 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 6 |
| 1205 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2015 | experimental therapy | Poland | below 1 |
| 1206 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 8 |
| 1207 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 46 |
| 1208 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2015 | experimental therapy | Poland | 26 |
| 1209 | cord tissue (Wharton's jelly) | allo-unrelated | severe developmental delay | neurology | 2015 | experimental therapy | Poland | 1 |
| 1210 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2015 | experimental therapy | Poland | 10 |
| 1211 | cord tissue (Wharton's jelly) | allo-unrelated | facio-scapulo-humeral muscular dystrophy | neurology | 2015 | experimental therapy | Poland | 30 |
| 1212 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 58 |
| 1213 | cord tissue (Wharton's jelly) | allo-unrelated | stroke | neurology | 2015 | experimental therapy | Poland | 62 |
| 1214 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 37 |
| 1215 | cord tissue (Wharton's jelly) | allo-unrelated | polineuropathy | neurology | 2015 | experimental therapy | Poland | 74 |
| 1216 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 5 |
| 1217 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 67 |
| 1218 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 24 |
| 1219 | cord tissue (Wharton's jelly) | allo-unrelated | cerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 18 |
| 1220 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2015 | experimental therapy | Poland | 2 |
| 1221 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development | neurology | 2015 | experimental therapy | Poland | 3 |
| 1222 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2015 | experimental therapy | Poland | 33 |
| 1223 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 22 |
| 1224 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 32 |
| 1225 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 63 |
| 1226 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 4 |
| 1227 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 6 |
| 1228 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 4 |
| 1229 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 27 |
| 1230 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 26 |
| 1231 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 12 |
| 1232 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 51 |
| 1233 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 62 |
| 1234 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2015 | experimental therapy | Poland | 45 |
| 1235 | cord tissue (Wharton's jelly) | allo-unrelated | iatrogenic spinal cord injury | neurology | 2015 | experimental therapy | Poland | 17 |
| 1236 | cord tissue (Wharton's jelly) | allo-unrelated | gonarthrosis | orthopedics | 2015 | experimental therapy | Poland | 66 |
| 1237 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
| 1238 | cord tissue (Wharton's jelly) | allo-unrelated | optic neuropathy | ophthalmology | 2015 | experimental therapy | Poland | 15 |
| 1239 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 44 |
| 1240 | cord tissue (Wharton's jelly) | allo-unrelated | spinal muscular atrophy | neurology | 2015 | experimental therapy | Poland | below 1 |
| 1241 | cord tissue (Wharton's jelly) | allo-unrelated | spinocerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 35 |
| 1242 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 58 |
| 1243 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 37 |
| 1244 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 26 |
| 1245 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 40 |
| 1246 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy | neurology | 2015 | experimental therapy | Poland | 11 |
| 1247 | cord tissue (Wharton's jelly) | allo-unrelated | adrenoleukodystrophy; encephalopathy | neurology | 2015 | experimental therapy | Poland | 23 |
| 1248 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 2 |
| 1249 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 18 |
| 1250 | cord tissue (Wharton's jelly) | allo-unrelated | traumatic encephalopathy | neurology | 2015 | experimental therapy | Poland | 20 |
| 1251 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
| 1252 | cord tissue (Wharton's jelly) | allo-unrelated | delayed psychomotor development, deafness | neurology | 2015 | experimental therapy | Poland | 3 |
| 1253 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 8 |
| 1254 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 12 |
| 1255 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 5 |
| 1256 | cord tissue (Wharton's jelly) | allo-unrelated | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 31 |
| 1257 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 59 |
| 1258 | cord tissue (Wharton's jelly) | allo-unrelated | spina bifida | neurology | 2015 | experimental therapy | Poland | 2 |
| 1259 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 13 |
| 1260 | cord tissue (Wharton's jelly) | allo-unrelated allo-related | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 7 |
| 1261 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 3 |
| 1262 | cord tissue (Wharton's jelly) | allo-unrelated | ceroid lipofuscinosis | neurology | 2015 | experimental therapy | Poland | 7 |
| 1263 | cord tissue (Wharton's jelly) | allo-unrelated | encephalopathy | neurology | 2015 | experimental therapy | Poland | 14 |
| 1264 | cord tissue (Wharton's jelly) | allo-unrelated | ceroid lipofuscinosis | neurology | 2015 | experimental therapy | Poland | 5 |
| 1265 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 15 |
| 1266 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 7 |
| 1267 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | below 1 |
| 1268 | cord tissue (Wharton's jelly) | allo-unrelated | bilateral blindness | ophthalmology | 2015 | experimental therapy | Poland | 36 |
| 1269 | cord tissue (Wharton's jelly) | allo-unrelated | decerebration rigidity | neurology | 2015 | experimental therapy | Poland | 9 |
| 1270 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 3 |
| 1271 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 52 |
| 1272 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 60 |
| 1273 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 65 |
| 1274 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 51 |
| 1275 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 56 |
| 1276 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
| 1277 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
| 1278 | cord tissue (Wharton's jelly) | allo-unrelated | sclerosis multiplex | neurology | 2015 | experimental therapy | Poland | 23 |
| 1279 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2015 | experimental therapy | Poland | 5 |
| 1280 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 1 |
| 1281 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2014 | experimental therapy | Poland | 15 |
| 1282 | cord tissue (Wharton's jelly) | allo-unrelated | cerebral palsy | neurology | 2014 | experimental therapy | Poland | 4 |
| 1283 | cord tissue (Wharton's jelly) | allo-unrelated | birth asphyxia; retinopathy | neurology | 2014 | experimental therapy | Poland | below 1 |
| 1284 | cord tissue (Wharton's jelly) | allo-unrelated | muscular dystrophy | neurology | 2014 | experimental therapy | Poland | 6 |
| 1285 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2014 | experimental therapy | Poland | 8 |
| 1286 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2014 | experimental therapy | Poland | 24 |
| 1287 | cord tissue (Wharton's jelly) | allo-unrelated | amyotrophic lateral sclerosis | neurology | 2014 | experimental therapy | Poland | 60 |
| 1288 | cord tissue (Wharton's jelly) | allo-unrelated | central motor coordination impairment after hypoxic ischaemia lesion at birth | neurology | 2014 | experimental therapy | Poland | 2 |
| 1289 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2014 | experimental therapy | Poland | 6 |
| 1290 | cord tissue (Wharton's jelly) | allo-unrelated | autism | neurology | 2014 | experimental therapy | Poland | 12 |
| 1291 | cord tissue (Wharton's jelly) | allo-unrelated | neuropathy | neurology | 2014 | experimental therapy | Poland | 23 |
| 1292 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2013 | experimental therapy | Poland | 17 |
| 1293 | cord tissue (Wharton's jelly) | allo-unrelated | chronic graft versus host disease | hematology | 2013 | experimental therapy | Poland | 18 |
| 1294 | cord tissue (Wharton's jelly) | allo-unrelated | acute myeloid leukemia | hematology | 2013 | experimental therapy | Poland | 3 |
| 1295 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2013 | experimental therapy | Poland | 3 |
| 1296 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2013 | experimental therapy | Poland | 2 |
| 1297 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2013 | experimental therapy | Poland | 18 |
| 1298 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2012 | experimental therapy | Poland | 4 |
| 1299 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2012 | experimental therapy | Poland | 7 |
| 1300 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2012 | experimental therapy | Poland | 19 |
| 1301 | cord tissue (Wharton's jelly) | allo-unrelated | acute graft versus host disease | hematology | 2011 | experimental therapy | Poland | 17 |
| 1302 | bone marrow | allogeneic | OHIS - other histiocytic disorders | hematology | 2019 | standard therapy | USA | 5 |
| 1303 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Germany | 8 |
| 1304 | bone marrow | allogeneic | C-HHYP cartilage-hair hypoplasia | hematology | 2019 | standard therapy | USA | 2 |
| 1305 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 63 |
| 1306 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 67 |
| 1307 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 5 |
| 1308 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 49 |
| 1309 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Norway | 47 |
| 1310 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2019 | standard therapy | India | 17 |
| 1311 | bone marrow | allogeneic | thalassemia major | hematology | 2019 | standard therapy | Turkey | 5 |
| 1312 | bone marrow | allogeneic | myeloproliferative syndrome | hematology | 2019 | standard therapy | Turkey | 2 |
| 1313 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Norway | 15 |
| 1314 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2019 | standard therapy | Italy | 5 |
| 1315 | bone marrow | allogeneic | Hurler syndrome | hematology | 2019 | standard therapy | USA | 2 |
| 1316 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2019 | standard therapy | France | 7 |
| 1317 | bone marrow | allogeneic | Nijmegen breakage syndrome | hematology | 2019 | standard therapy | Poland | 6 |
| 1318 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 4 |
| 1319 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Slovakia | 10 |
| 1320 | bone marrow | allogeneic | Diamond-Balckfan anaemia | hematology | 2019 | standard therapy | Poland | 2 |
| 1321 | bone marrow | allogeneic | severe aplastic anaemia | hematologia | 2019 | standard therapy | USA | 12 |
| 1322 | bone marrow | allogeneic | acute myelogenous leukemia | hematologia | 2019 | standard therapy | Australia | 65 |
| 1323 | bone marrow | allogeneic | no data | hematologia | 2019 | standard therapy | Poland | 1 |
| 1324 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematologia | 2019 | standard therapy | Spain | 42 |
| 1325 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematologia | 2019 | standard therapy | USA | 17 |
| 1326 | bone marrow | allogeneic | chronic myeloid leukemia | hematologia | 2019 | standard therapy | Poland | 9 |
| 1327 | bone marrow | allogeneic | osteopetrosis | hematologia | 2019 | standard therapy | Israel | 1 |
| 1328 | bone marrow | allogeneic | aplastic anaemia | hematologia | 2019 | standard therapy | Spain | 10 |
| 1329 | bone marrow | allogeneic | congenital amegakaryocytic thrombocytopenia | hematologia | 2019 | standard therapy | United Kingdom | 1 |
| 1330 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematologia | 2019 | standard therapy | France | 21 |
| 1331 | bone marrow | allogeneic | acute myelogenous leukemia | hematologia | 2019 | standard therapy | Canada | 14 |
| 1332 | bone marrow | allogeneic | myelodysplastic syndrome | hematologia | 2019 | standard therapy | USA | 57 |
| 1333 | bone marrow | allogeneic | myelodysplastic syndrome | hematologia | 2019 | standard therapy | USA | 75 |
| 1334 | bone marrow | allogeneic | thalassemia major | hematologia | 2019 | standard therapy | Sweden | 13 |
| 1335 | bone marrow | allogeneic | severe aplastic anaemia | hematologia | 2019 | standard therapy | Germany | 11 |
| 1336 | bone marrow | allogeneic | Fanconi Aplastic Anemia | hematology | 2019 | standard therapy | Turkey | 6 |
| 1337 | bone marrow | allogeneic | no data | hematology | 2019 | standard therapy | United Kingdom | 3 |
| 1338 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 66 |
| 1339 | bone marrow | allogeneic | aplastic anaemia | hematology | 2019 | standard therapy | Romania | 8 |
| 1340 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Poland | 5 |
| 1341 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | USA | 52 |
| 1342 | bone marrow | allogeneic | no data | hematology | 2019 | standard therapy | Italy | 59 |
| 1343 | bone marrow | allogeneic | aplastic anaemia | hematology | 2019 | standard therapy | Canada | 18 |
| 1344 | bone marrow | allogeneic | acute lymphoblastic leukemia relapse | hematology | 2018 | standard therapy | Germany | 14 |
| 1345 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 53 |
| 1346 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Turkey | 21 |
| 1347 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | Brazil | 1 |
| 1348 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 60 |
| 1349 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 22 |
| 1350 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Canada | 37 |
| 1351 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Canada | 18 |
| 1352 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Iran | 6 |
| 1353 | bone marrow | allogeneic | congenital hypoplastic anemia | hematology | 2018 | standard therapy | Canada | 2 |
| 1354 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Germany | 20 |
| 1355 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2018 | standard therapy | Brazil | 3 |
| 1356 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 6 |
| 1357 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 40 |
| 1358 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 72 |
| 1359 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | USA | 1 |
| 1360 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | Germany | 1 |
| 1361 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 31 |
| 1362 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 52 |
| 1363 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 12 |
| 1364 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 2 |
| 1365 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Australia | 59 |
| 1366 | bone marrow | allogeneic | other non-malignant disease | hematology | 2018 | standard therapy | USA | 29 |
| 1367 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | United Kingdom | 6 |
| 1368 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Poland | 18 |
| 1369 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 8 |
| 1370 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Poland | below 1 |
| 1371 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 14 |
| 1372 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 70 |
| 1373 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Hungary | 4 |
| 1374 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 4 |
| 1375 | bone marrow | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 62 |
| 1376 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 66 |
| 1377 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 25 |
| 1378 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | USA | 2 |
| 1379 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 17 |
| 1380 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 32 |
| 1381 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Austria | 8 |
| 1382 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 7 |
| 1383 | bone marrow | allogeneic | T-cell leukemia/lymphoma | hematology | 2018 | standard therapy | Argentina | 10 |
| 1384 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Belgium | 41 |
| 1385 | bone marrow | allogeneic | thalassemia major | hematology | 2018 | standard therapy | Turkey | 12 |
| 1386 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 66 |
| 1387 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 3 |
| 1388 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | India | 27 |
| 1389 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 49 |
| 1390 | bone marrow | allogeneic | aplastic anaemia | hematology | 2018 | standard therapy | Poland | 24 |
| 1391 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 70 |
| 1392 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | France | 2 |
| 1393 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 71 |
| 1394 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 8 |
| 1395 | bone marrow | allogeneic | Hurler syndrome | hematology | 2018 | standard therapy | USA | 2 |
| 1396 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 12 |
| 1397 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2018 | standard therapy | USA | 3 |
| 1398 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 1 |
| 1399 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Canada | 8 |
| 1400 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 20 |
| 1401 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | USA | 1 |
| 1402 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | USA | 2 |
| 1403 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Argentina | 14 |
| 1404 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 11 |
| 1405 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Italy | 14 |
| 1406 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Israel | 2 |
| 1407 | bone marrow | allogeneic | diffuse large B-cell lymphoma | hematology | 2018 | standard therapy | Germany | 68 |
| 1408 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 50 |
| 1409 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 19 |
| 1410 | bone marrow | allogeneic | thalassemia major | hematology | 2018 | standard therapy | Sweden | 14 |
| 1411 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 36 |
| 1412 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 12 |
| 1413 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 16 |
| 1414 | bone marrow | allogeneic | no data | hematology | 2018 | standard therapy | Spain | 48 |
| 1415 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Brazil | 3 |
| 1416 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Switzerland | 67 |
| 1417 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | below 1 |
| 1418 | bone marrow | allogeneic | bilineal leukemia -acute lymphoblastic leukemia, acute myelogenous leukemia | hematology | 2018 | standard therapy | Belarus | 2 |
| 1419 | bone marrow | allogeneic | Hodgkin’s lymphoma | hematology | 2018 | standard therapy | USA | 31 |
| 1420 | bone marrow | allogeneic | juvenile myelomonocytic leukemia | hematology | 2018 | standard therapy | Hungary | 11 |
| 1421 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | Switzerland | 3 |
| 1422 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 4 |
| 1423 | bone marrow | allogeneic | primary Immunodeficiency; Nijmegen breakage syndrome | hematology | 2017 | standard therapy | Belarus | 6 |
| 1424 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 19 |
| 1425 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Hungary | 7 |
| 1426 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2017 | standard therapy | Belarus | 10 |
| 1427 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Turkey | 8 |
| 1428 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 2 |
| 1429 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 18 |
| 1430 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | India | 7 |
| 1431 | bone marrow | allogeneic | secondary acute myelogenous leukemia after Ewing sarcoma | hematology | 2017 | standard therapy | Germany | 16 |
| 1432 | bone marrow | allogeneic | Nijmegen breakage syndrome | hematology | 2017 | standard therapy | Poland | 8 |
| 1433 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Norway | 2 |
| 1434 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 12 |
| 1435 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 2 |
| 1436 | bone marrow | allogeneic | other combined immunodeficiency | hematology | 2017 | standard therapy | USA | 11 |
| 1437 | bone marrow | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | Canada | 50 |
| 1438 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 7 |
| 1439 | bone marrow | allogeneic | T-cell leukemia/lymphoma | hematology | 2017 | standard therapy | Iran | 18 |
| 1440 | bone marrow | allogeneic | Wiskott-Aldrich syndrome | hematology | 2017 | standard therapy | Iran | 2 |
| 1441 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 4 |
| 1442 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Brazil | 14 |
| 1443 | bone marrow | allogeneic | no data | hematology | 2017 | standard therapy | France | 32 |
| 1444 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 9 |
| 1445 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 8 |
| 1446 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Poland | 1 |
| 1447 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 24 |
| 1448 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 54 |
| 1449 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 56 |
| 1450 | bone marrow | allogeneic | chronic myeloid leukemia | hematology | 2017 | standard therapy | USA | 51 |
| 1451 | bone marrow | allogeneic | acute megakaryocytic leukemia | hematology | 2017 | standard therapy | Spain | 2 |
| 1452 | bone marrow | allogeneic | juvenile myelomonocytic leukemia | hematology | 2017 | standard therapy | Finland | 1 |
| 1453 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 51 |
| 1454 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 17 |
| 1455 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 10 |
| 1456 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2017 | standard therapy | Russia | 10 |
| 1457 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 60 |
| 1458 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Czech Republic | 68 |
| 1459 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 10 |
| 1460 | bone marrow | allogeneic | thalassemia major | hematology | 2017 | standard therapy | Turkey | 11 |
| 1461 | bone marrow | allogeneic | pure red cell aplasia | hematology | 2017 | standard therapy | USA | 5 |
| 1462 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 57 |
| 1463 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 59 |
| 1464 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 1 |
| 1465 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Austria | 3 |
| 1466 | bone marrow | allogeneic | hyper IgM syndrome | hematology | 2017 | standard therapy | Finland | 2 |
| 1467 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Turkey | 2 |
| 1468 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 21 |
| 1469 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 59 |
| 1470 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Canada | 1 |
| 1471 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 9 |
| 1472 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 38 |
| 1473 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 13 |
| 1474 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Lithuania | 1 |
| 1475 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 16 |
| 1476 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 67 |
| 1477 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 55 |
| 1478 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2017 | standard therapy | Turkey | 6 |
| 1479 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Hungary | 14 |
| 1480 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 10 |
| 1481 | bone marrow | allogeneic | leukemia | hematology | 2017 | standard therapy | USA | 40 |
| 1482 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2017 | standard therapy | Poland | 4 |
| 1483 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Russia | 30 |
| 1484 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 61 |
| 1485 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Italy | 60 |
| 1486 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 65 |
| 1487 | bone marrow | allogeneic | chronic granulomatous disease | hematology | 2017 | standard therapy | Poland | 2 |
| 1488 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 22 |
| 1489 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 76 |
| 1490 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 6 |
| 1491 | bone marrow | allogeneic | high-risk acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 18 |
| 1492 | bone marrow | allogeneic | anaemia | hematology | 2016 | standard therapy | Italy | 5 |
| 1493 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 6 |
| 1494 | bone marrow | allogeneic | anaemia | hematology | 2016 | standard therapy | Germany | 16 |
| 1495 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Finland | 45 |
| 1496 | bone marrow | allogeneic | juvenile myelomonocytic leukemia | hematology | 2016 | standard therapy | Germany | 3 |
| 1497 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belarus | 15 |
| 1498 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 9 |
| 1499 | bone marrow | allogeneic | Diamond-Balckfan anaemia | hematology | 2016 | standard therapy | Germany | 2 |
| 1500 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Ireland | 39 |
| 1501 | bone marrow | allogeneic | myeloproliferative syndrome | hematology | 2016 | standard therapy | Poland | 22 |
| 1502 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Croatia | 33 |
| 1503 | bone marrow | allogeneic | aplastic anaemia | hematology | 2016 | standard therapy | Austria | 20 |
| 1504 | bone marrow | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Italy | 46 |
| 1505 | bone marrow | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 33 |
| 1506 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 5 |
| 1507 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2016 | standard therapy | Germany | 12 |
| 1508 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | New Zealand | 1 |
| 1509 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belarus | 25 |
| 1510 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 29 |
| 1511 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 5 |
| 1512 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2016 | standard therapy | Netherlands | 41 |
| 1513 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Spain | 56 |
| 1514 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 67 |
| 1515 | bone marrow | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Hungary | 1 |
| 1516 | bone marrow | allogeneic | severe aplastic anaemia / paroxymal nocturnal haemoglobinuria | hematology | 2016 | standard therapy | Poland | 17 |
| 1517 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2016 | standard therapy | France | 9 |
| 1518 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2016 | standard therapy | Poland | below 1 |
| 1519 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belarus | 18 |
| 1520 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Belarus | 12 |
| 1521 | bone marrow | allogeneic | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Italy | 17 |
| 1522 | bone marrow | allogeneic | DiGeorge syndrome | hematology | 2016 | standard therapy | Netherlands | 24 |
| 1523 | bone marrow | allogeneic | myelofibrosis | hematology | 2016 | standard therapy | Germany | 31 |
| 1524 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Canada | 11 |
| 1525 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2016 | standard therapy | Turkey | 4 |
| 1526 | bone marrow | allogeneic | Hurler syndrome | metabolic | 2016 | standard therapy | United Kingdom | 2 |
| 1527 | bone marrow | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 7 |
| 1528 | bone marrow | allogeneic | severe aplastic anaemia | hematology | 2016 | standard therapy | France | 9 |
| 1529 | bone marrow | allogeneic | osteopetrosis | metabolic | 2016 | standard therapy | Germany | 1 |
| 1530 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 7 |
| 1531 | bone marrow | allogeneic | biphenotypic leukemia | hematology | 2016 | standard therapy | Brazil | 27 |
| 1532 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 14 |
| 1533 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 64 |
| 1534 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 6 |
| 1535 | bone marrow | allogeneic | Fanconi anaemia | hematology | 2016 | standard therapy | Estonia | 7 |
| 1536 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Spain | 55 |
| 1537 | bone marrow | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 9 |
| 1538 | bone marrow | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 64 |
| 1539 | bone marrow | allogeneic | no data | n/a | 2016 | standard therapy | Italy | 3 |
| 1540 | bone marrow | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 4 |
| 1541 | bone marrow | allogeneic | severe combined immunodeficiency | hematology | 2016 | standard therapy | Romania | 2 |
| 1542 | bone marrow | allogeneic | osteopetrosis | metabolic | 2016 | standard therapy | Russia | 6 |
| 1543 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Germany | 62 |
| 1544 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Poland | 51 |
| 1545 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 63 |
| 1546 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 61 |
| 1547 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 62 |
| 1548 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 68 |
| 1549 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 53 |
| 1550 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 29 |
| 1551 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Turkey | 56 |
| 1552 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Czechia | 29 |
| 1553 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 52 |
| 1554 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 59 |
| 1555 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | France | 72 |
| 1556 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2019 | standard therapy | USA | 58 |
| 1557 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 65 |
| 1558 | peripheral blood | allogeneic | primary myelofibrosis | hematology | 2019 | standard therapy | Turkey | 46 |
| 1559 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2019 | standard therapy | Poland | 65 |
| 1560 | peripheral blood | allogeneic | other myleofibrosis | hematology | 2019 | standard therapy | USA | 61 |
| 1561 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Netherlands | 42 |
| 1562 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 65 |
| 1563 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 68 |
| 1564 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Turkey | 42 |
| 1565 | peripheral blood | allogeneic | other myleofibrosis | hematology | 2019 | standard therapy | USA | 70 |
| 1566 | peripheral blood | allogeneic | B-cell acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Germany | 8 |
| 1567 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Hungary | 43 |
| 1568 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2019 | standard therapy | Italy | 37 |
| 1569 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Switzerland | 58 |
| 1570 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 60 |
| 1571 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Croatia | 55 |
| 1572 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 61 |
| 1573 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Netherlands | 66 |
| 1574 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 54 |
| 1575 | peripheral blood | allogeneic | extracranial malignant germ cell tumors | hematology | 2019 | standard therapy | USA | 53 |
| 1576 | peripheral blood | allogeneic | no data | hematology | 2019 | standard therapy | Germany | 20 |
| 1577 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2019 | standard therapy | Italy | 45 |
| 1578 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Australia | 59 |
| 1579 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | United Kingdom | 50 |
| 1580 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 73 |
| 1581 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 72 |
| 1582 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Germany | 15 |
| 1583 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 65 |
| 1584 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | USA | 20 |
| 1585 | peripheral blood | allogeneic | myelofibrosis | hematology | 2019 | standard therapy | Italy | 60 |
| 1586 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Hungary | 40 |
| 1587 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Poland | 45 |
| 1588 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2019 | standard therapy | USA | 69 |
| 1589 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 62 |
| 1590 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 45 |
| 1591 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Iran | 45 |
| 1592 | peripheral blood | allogeneic | high risk myelodysplastic syndrome | hematology | 2019 | standard therapy | Italy | 61 |
| 1593 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Romania | 18 |
| 1594 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Germany | 69 |
| 1595 | peripheral blood | allogeneic | Glanzmann thrombasthenia | hematology | 2019 | standard therapy | Germany | 11 |
| 1596 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 72 |
| 1597 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Italy | 56 |
| 1598 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 37 |
| 1599 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2019 | standard therapy | Turkey | 11 |
| 1600 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 72 |
| 1601 | peripheral blood | allogeneic | myelofibrosis | hematology | 2019 | standard therapy | United Kingdom | 46 |
| 1602 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Germany | 70 |
| 1603 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Poland | 63 |
| 1604 | peripheral blood | allogeneic | Wiskott-Aldrich syndrome | hematology | 2019 | standard therapy | Poland | 1 |
| 1605 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 69 |
| 1606 | peripheral blood | allogeneic | no data | hematology | 2019 | standard therapy | Germany | 66 |
| 1607 | peripheral blood | allogeneic | myelofibrosis with myeloid metaplasia | hematology | 2019 | standard therapy | USA | 63 |
| 1608 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | France | 52 |
| 1609 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Argentina | 45 |
| 1610 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 75 |
| 1611 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Germany | 44 |
| 1612 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2019 | standard therapy | Poland | 28 |
| 1613 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Germany | 61 |
| 1614 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | United Kingdom | 60 |
| 1615 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | USA | 65 |
| 1616 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 29 |
| 1617 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | France | 62 |
| 1618 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2019 | standard therapy | Denmark | 65 |
| 1619 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2019 | standard therapy | Italy | 56 |
| 1620 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 60 |
| 1621 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2019 | standard therapy | United Kingdom | 34 |
| 1622 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 60 |
| 1623 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2019 | standard therapy | Germany | 68 |
| 1624 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | France | 61 |
| 1625 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | USA | 67 |
| 1626 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 49 |
| 1627 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Switzerland | 55 |
| 1628 | peripheral blood | allogeneic | myelofibrosis with myeloid metaplasia | hematology | 2019 | standard therapy | USA | 69 |
| 1629 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | France | 70 |
| 1630 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2019 | standard therapy | United Kingdom | 23 |
| 1631 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Germany | 14 |
| 1632 | peripheral blood | allogeneic | primary immunodeficiency | hematology | 2019 | standard therapy | United Kingdom | 21 |
| 1633 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Bulgaria | 47 |
| 1634 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Argentina | 60 |
| 1635 | peripheral blood | allogeneic | osteomielofibrosis - other | hematology | 2019 | standard therapy | USA | 63 |
| 1636 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Poland | 27 |
| 1637 | peripheral blood | allogeneic | paroxysmal nocturnal hemoglobinuria | hematology | 2019 | standard therapy | Poland | 24 |
| 1638 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 69 |
| 1639 | peripheral blood | allogeneic | mixed phenotype acute leukemia | hematology | 2019 | standard therapy | Germany | 59 |
| 1640 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | United Kingdom | 67 |
| 1641 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 57 |
| 1642 | peripheral blood | allogeneic | mycosis fungoides | hematology | 2019 | standard therapy | Finland | 52 |
| 1643 | peripheral blood | allogeneic | myelofibrosis with myeloid metaplasia | hematology | 2019 | standard therapy | USA | 66 |
| 1644 | peripheral blood | allogeneic | mantle cell lymphoma | hematology | 2019 | standard therapy | Poland | 62 |
| 1645 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 59 |
| 1646 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Ireland | 38 |
| 1647 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2019 | standard therapy | Finland | 48 |
| 1648 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Australia | 57 |
| 1649 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2019 | standard therapy | Turkey | 54 |
| 1650 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Poland | 62 |
| 1651 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 53 |
| 1652 | peripheral blood | allogeneic | no data | hematology | 2019 | standard therapy | Poland | 43 |
| 1653 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2019 | standard therapy | USA | 65 |
| 1654 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2019 | standard therapy | Istanbul | 4 |
| 1655 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | USA | 55 |
| 1656 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2019 | standard therapy | USA | 58 |
| 1657 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 36 |
| 1658 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 54 |
| 1659 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2019 | standard therapy | Belgium | 62 |
| 1660 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 37 |
| 1661 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Poland | 62 |
| 1662 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | USA | 66 |
| 1663 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 53 |
| 1664 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Turkey | 39 |
| 1665 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Czech Republic | 65 |
| 1666 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2019 | standard therapy | Chile | 12 |
| 1667 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2019 | standard therapy | Germany | 63 |
| 1668 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 38 |
| 1669 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 67 |
| 1670 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 66 |
| 1671 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Greece | 46 |
| 1672 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | France | 67 |
| 1673 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 62 |
| 1674 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 14 |
| 1675 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 24 |
| 1676 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Lithuania | 46 |
| 1677 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Poland | 60 |
| 1678 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 61 |
| 1679 | peripheral blood | allogeneic | peripheral T-cell lymphoma | hematology | 2018 | standard therapy | Germany | 50 |
| 1680 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 63 |
| 1681 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Greece | 47 |
| 1682 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 41 |
| 1683 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 58 |
| 1684 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 8 |
| 1685 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Lithuania | 9 |
| 1686 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Greece | 45 |
| 1687 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 67 |
| 1688 | peripheral blood | allogeneic | atypical chronic myeloid leukemia | hematology | 2018 | standard therapy | USA | 58 |
| 1689 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Germany | 52 |
| 1690 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2018 | standard therapy | Poland | 27 |
| 1691 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Turkey | 61 |
| 1692 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 62 |
| 1693 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Slovakia | 56 |
| 1694 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 55 |
| 1695 | peripheral blood | allogeneic | myelodysplastic syndrome - RAEB | hematology | 2018 | standard therapy | Germany | 61 |
| 1696 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 34 |
| 1697 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Poland | 53 |
| 1698 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Lithuania | 52 |
| 1699 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Greece | 46 |
| 1700 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 55 |
| 1701 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Romania | 37 |
| 1702 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Italy | 49 |
| 1703 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 72 |
| 1704 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 20 |
| 1705 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Greece | 43 |
| 1706 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 75 |
| 1707 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 34 |
| 1708 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Poland | 54 |
| 1709 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 8 |
| 1710 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Argentina | 25 |
| 1711 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 59 |
| 1712 | peripheral blood | allogeneic | non-Hodgkin lymphoma; diffuse large B-cell lymphoma | hematology | 2018 | standard therapy | Germany | 62 |
| 1713 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Slovakia | 40 |
| 1714 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Bulgaria | 57 |
| 1715 | peripheral blood | allogeneic | Chronic granulomatous disease | hematology | 2018 | standard therapy | Russia | 2 |
| 1716 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 63 |
| 1717 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Macedonia | 22 |
| 1718 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | USA | 72 |
| 1719 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 34 |
| 1720 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 40 |
| 1721 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | United Kingdom | 69 |
| 1722 | peripheral blood | allogeneic | Hypoplastic MDS-EB2 with incipient sAML | hematology | 2018 | standard therapy | Germany | 63 |
| 1723 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 65 |
| 1724 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 59 |
| 1725 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 13 |
| 1726 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 54 |
| 1727 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 66 |
| 1728 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 54 |
| 1729 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 67 |
| 1730 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Germany | 45 |
| 1731 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 48 |
| 1732 | peripheral blood | allogeneic | plasma cell disorder | hematology | 2018 | standard therapy | France | 57 |
| 1733 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Poland | 30 |
| 1734 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 68 |
| 1735 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 4 |
| 1736 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2018 | standard therapy | United Kingdom | 41 |
| 1737 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Netherlands | 67 |
| 1738 | peripheral blood | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Poland | 2 |
| 1739 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 34 |
| 1740 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 64 |
| 1741 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | USA | 67 |
| 1742 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Belgium | 49 |
| 1743 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 30 |
| 1744 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 60 |
| 1745 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 52 |
| 1746 | peripheral blood | allogeneic | prolymphocytic leukemia | hematology | 2018 | standard therapy | USA | 62 |
| 1747 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 32 |
| 1748 | peripheral blood | allogeneic | B-cell Chronic lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 65 |
| 1749 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Spain | 46 |
| 1750 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Czech Republic | 57 |
| 1751 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 55 |
| 1752 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Belgium | 58 |
| 1753 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 19 |
| 1754 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 60 |
| 1755 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 45 |
| 1756 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 58 |
| 1757 | peripheral blood | allogeneic | myeloproliferative neoplasms | hematology | 2018 | standard therapy | Germany | 61 |
| 1758 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Spain | 51 |
| 1759 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Canada | 60 |
| 1760 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 59 |
| 1761 | peripheral blood | allogeneic | therapy-related myelodysplastic syndromes | hematology | 2018 | standard therapy | Germany | 65 |
| 1762 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Germany | 11 |
| 1763 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2018 | standard therapy | USA | 25 |
| 1764 | peripheral blood | allogeneic | follicular lymphoma (non-Hodgkin lymphoma) | hematology | 2018 | standard therapy | Czech Republic | 56 |
| 1765 | peripheral blood | allogeneic | thalassemia major | hematology | 2018 | standard therapy | Germany | 5 |
| 1766 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 44 |
| 1767 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Netherlands | 31 |
| 1768 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 71 |
| 1769 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 48 |
| 1770 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 20 |
| 1771 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Russia | 6 |
| 1772 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 56 |
| 1773 | peripheral blood | allogeneic | chronic granulomatous disease | hematology | 2018 | standard therapy | USA | 15 |
| 1774 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 66 |
| 1775 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 49 |
| 1776 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 6 |
| 1777 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 60 |
| 1778 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 65 |
| 1779 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 57 |
| 1780 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 67 |
| 1781 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | USA | 68 |
| 1782 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 36 |
| 1783 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 37 |
| 1784 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 29 |
| 1785 | peripheral blood | allogeneic | other malignancy | hematology | 2018 | standard therapy | Italy | 59 |
| 1786 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 47 |
| 1787 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2018 | standard therapy | USA | 48 |
| 1788 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 46 |
| 1789 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 64 |
| 1790 | peripheral blood | allogeneic | primary Immunodeficiency | hematology | 2018 | standard therapy | Russia | 3 |
| 1791 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 55 |
| 1792 | peripheral blood | allogeneic | relapsed peripheral T cell lymphoma | hematology | 2018 | standard therapy | Canada | 44 |
| 1793 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 62 |
| 1794 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 71 |
| 1795 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 52 |
| 1796 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2018 | standard therapy | Italy | 38 |
| 1797 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Canada | 63 |
| 1798 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 28 |
| 1799 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 67 |
| 1800 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 69 |
| 1801 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Denmark | 59 |
| 1802 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 63 |
| 1803 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Czech Republic | 22 |
| 1804 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 71 |
| 1805 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 70 |
| 1806 | peripheral blood | allogeneic | other myelodysplastic syndromes | hematology | 2018 | standard therapy | USA | 67 |
| 1807 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Israel | 32 |
| 1808 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Austria | 45 |
| 1809 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Sweden | 60 |
| 1810 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 64 |
| 1811 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Poland | 71 |
| 1812 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Belgium | 64 |
| 1813 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 38 |
| 1814 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 59 |
| 1815 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Italy | 58 |
| 1816 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 32 |
| 1817 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2018 | standard therapy | Poland | 49 |
| 1818 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Turkey | 60 |
| 1819 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 46 |
| 1820 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 25 |
| 1821 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 71 |
| 1822 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 31 |
| 1823 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2018 | standard therapy | Sweden | 63 |
| 1824 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | below 1 |
| 1825 | peripheral blood | allogeneic | follicular lymphoma | hematology | 2018 | standard therapy | Lithuania | 44 |
| 1826 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 50 |
| 1827 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 17 |
| 1828 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 54 |
| 1829 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Poland | 24 |
| 1830 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Belgium | 27 |
| 1831 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 39 |
| 1832 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | Netherlands | 56 |
| 1833 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Serbia | 39 |
| 1834 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Netherlands | 66 |
| 1835 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Sutherland | 59 |
| 1836 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Lithuania | 21 |
| 1837 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 67 |
| 1838 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 33 |
| 1839 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 70 |
| 1840 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Spain | 53 |
| 1841 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 45 |
| 1842 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 74 |
| 1843 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Brazil | 39 |
| 1844 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 27 |
| 1845 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Brazil | 3 |
| 1846 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 58 |
| 1847 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Bulgaria | 61 |
| 1848 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 40 |
| 1849 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 70 |
| 1850 | peripheral blood | allogeneic | plasma cell disorder | hematology | 2018 | standard therapy | France | 64 |
| 1851 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Russia | 33 |
| 1852 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 61 |
| 1853 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Brazil | 71 |
| 1854 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 55 |
| 1855 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 72 |
| 1856 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Hungary | 42 |
| 1857 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Canada | 58 |
| 1858 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Germany | 38 |
| 1859 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 63 |
| 1860 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 63 |
| 1861 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Belgium | 32 |
| 1862 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 56 |
| 1863 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Argentina | 1 |
| 1864 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Germany | 57 |
| 1865 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 62 |
| 1866 | peripheral blood | allogeneic | blastic NK cell lymphoma | hematology | 2018 | standard therapy | Germany | 65 |
| 1867 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 42 |
| 1868 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Belgium | 70 |
| 1869 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 3 |
| 1870 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | France | 70 |
| 1871 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Italy | 55 |
| 1872 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 8 |
| 1873 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 54 |
| 1874 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 33 |
| 1875 | peripheral blood | allogeneic | diffuse large B-cell lymphoma | hematology | 2018 | standard therapy | Poland | 54 |
| 1876 | peripheral blood | allogeneic | no data | hematology | 2018 | standard therapy | Poland | 69 |
| 1877 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 35 |
| 1878 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 57 |
| 1879 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Turkey | 27 |
| 1880 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 66 |
| 1881 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 52 |
| 1882 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Lithuania | 39 |
| 1883 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 20 |
| 1884 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 67 |
| 1885 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 68 |
| 1886 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 73 |
| 1887 | peripheral blood | allogeneic | severe combined immunodeficiency | hematology | 2018 | standard therapy | Turkey | 9 |
| 1888 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 67 |
| 1889 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 33 |
| 1890 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 60 |
| 1891 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 60 |
| 1892 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Croatia | 59 |
| 1893 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 65 |
| 1894 | peripheral blood | allogeneic | myelodysplastic syndrome; acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 74 |
| 1895 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 37 |
| 1896 | peripheral blood | allogeneic | leukemia | hematology | 2018 | standard therapy | Germany | 34 |
| 1897 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 66 |
| 1898 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Belgium | 68 |
| 1899 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 28 |
| 1900 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 49 |
| 1901 | peripheral blood | allogeneic | Fanconi anaemia | hematology | 2018 | standard therapy | USA | 9 |
| 1902 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | USA | 63 |
| 1903 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 31 |
| 1904 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Germany | 17 |
| 1905 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Sweden | 60 |
| 1906 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Sweden | 56 |
| 1907 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 25 |
| 1908 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2018 | standard therapy | USA | 39 |
| 1909 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 71 |
| 1910 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 60 |
| 1911 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 70 |
| 1912 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Switzerland | 50 |
| 1913 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Canada | 23 |
| 1914 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | USA | 69 |
| 1915 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Germany | 77 |
| 1916 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 58 |
| 1917 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 8 |
| 1918 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 38 |
| 1919 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 64 |
| 1920 | peripheral blood | allogeneic | primary myelofibrosis; secondary acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 53 |
| 1921 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 50 |
| 1922 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 76 |
| 1923 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 46 |
| 1924 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 61 |
| 1925 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | USA | 57 |
| 1926 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 64 |
| 1927 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Slovenia | 54 |
| 1928 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | United Kingdom | 22 |
| 1929 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 67 |
| 1930 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 54 |
| 1931 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 8 |
| 1932 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 62 |
| 1933 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 68 |
| 1934 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 13 |
| 1935 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 41 |
| 1936 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 62 |
| 1937 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 64 |
| 1938 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 47 |
| 1939 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 50 |
| 1940 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 61 |
| 1941 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 64 |
| 1942 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 51 |
| 1943 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 61 |
| 1944 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 59 |
| 1945 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 72 |
| 1946 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 54 |
| 1947 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 56 |
| 1948 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | Netherlands | 67 |
| 1949 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 42 |
| 1950 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 71 |
| 1951 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 30 |
| 1952 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 67 |
| 1953 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 45 |
| 1954 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 45 |
| 1955 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 61 |
| 1956 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 33 |
| 1957 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 50 |
| 1958 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 72 |
| 1959 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Germany | 60 |
| 1960 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Spain | 34 |
| 1961 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2018 | standard therapy | Poland | 38 |
| 1962 | peripheral blood | allogeneic | acute myeloid leukemia in first complete remission | hematology | 2018 | standard therapy | Germany | 61 |
| 1963 | peripheral blood | allogeneic | secondary acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 58 |
| 1964 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 46 |
| 1965 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 48 |
| 1966 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 65 |
| 1967 | peripheral blood | allogeneic | other myleofibrosis | hematology | 2018 | standard therapy | Poland | 57 |
| 1968 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 66 |
| 1969 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Poland | 23 |
| 1970 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 46 |
| 1971 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 63 |
| 1972 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2018 | standard therapy | Lithuania | 56 |
| 1973 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 7 |
| 1974 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2018 | standard therapy | Germany | 18 |
| 1975 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 74 |
| 1976 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 42 |
| 1977 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | United Kingdom | 29 |
| 1978 | peripheral blood | allogeneic | myelofibrosis | hematology | 2018 | standard therapy | Netherlands | 49 |
| 1979 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 59 |
| 1980 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 35 |
| 1981 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 26 |
| 1982 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 13 |
| 1983 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 71 |
| 1984 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Switzerland | 68 |
| 1985 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 8 |
| 1986 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 37 |
| 1987 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Belgium | 26 |
| 1988 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 10 |
| 1989 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 70 |
| 1990 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Germany | 60 |
| 1991 | peripheral blood | allogeneic | myelodysplastic syndrome in Fanconi anaemia | hematology | 2017 | standard therapy | Italy | 23 |
| 1992 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2017 | standard therapy | USA | 57 |
| 1993 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2017 | standard therapy | USA | 25 |
| 1994 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 72 |
| 1995 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 24 |
| 1996 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 63 |
| 1997 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 72 |
| 1998 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 69 |
| 1999 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 57 |
| 2000 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | Poland | 38 |
| 2001 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 27 |
| 2002 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 69 |
| 2003 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 40 |
| 2004 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Canada | 22 |
| 2005 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 61 |
| 2006 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | USA | 57 |
| 2007 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 64 |
| 2008 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Canada | 55 |
| 2009 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 61 |
| 2010 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 58 |
| 2011 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Germany | 72 |
| 2012 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 53 |
| 2013 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 71 |
| 2014 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 55 |
| 2015 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 68 |
| 2016 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 46 |
| 2017 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 26 |
| 2018 | peripheral blood | allogeneic | secondary acute myelogenous leukemia | hematology | 2017 | standard therapy | Austria | 24 |
| 2019 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2017 | standard therapy | Russia | 16 |
| 2020 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Israel | 6 |
| 2021 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 23 |
| 2022 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Israel | 37 |
| 2023 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 63 |
| 2024 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Sweden | 59 |
| 2025 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 50 |
| 2026 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 63 |
| 2027 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 68 |
| 2028 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Netherlands | 65 |
| 2029 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 55 |
| 2030 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 67 |
| 2031 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 66 |
| 2032 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Poland | 1 |
| 2033 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Sweden | 69 |
| 2034 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 53 |
| 2035 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 66 |
| 2036 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 52 |
| 2037 | peripheral blood | allogeneic | blastic plasmacytoid dendritic cell neoplasm | hematology | 2017 | standard therapy | Germany | 56 |
| 2038 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | USA | 47 |
| 2039 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 62 |
| 2040 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 24 |
| 2041 | peripheral blood | allogeneic | primary myelofibrosis | hematology | 2017 | standard therapy | Poland | 32 |
| 2042 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Netherlands | 71 |
| 2043 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 64 |
| 2044 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 21 |
| 2045 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Germany | 7 |
| 2046 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 57 |
| 2047 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 63 |
| 2048 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 43 |
| 2049 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Norway | 56 |
| 2050 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | USA | 51 |
| 2051 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Belgium | 69 |
| 2052 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Netherlands | 72 |
| 2053 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | France | 36 |
| 2054 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Spain | 28 |
| 2055 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Greece | 28 |
| 2056 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 17 |
| 2057 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 16 |
| 2058 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 53 |
| 2059 | peripheral blood | allogeneic | prolymphocytic leukemia | hematology | 2017 | standard therapy | Poland | 63 |
| 2060 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Italy | 61 |
| 2061 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 63 |
| 2062 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 59 |
| 2063 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 62 |
| 2064 | peripheral blood | allogeneic | primary myelofibrosis | hematology | 2017 | standard therapy | Germany | 29 |
| 2065 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 46 |
| 2066 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 62 |
| 2067 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 56 |
| 2068 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 68 |
| 2069 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | United Kingdom | 51 |
| 2070 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Finland | 58 |
| 2071 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Netherlands | 53 |
| 2072 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Hungary | 40 |
| 2073 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 61 |
| 2074 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 54 |
| 2075 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 57 |
| 2076 | peripheral blood | allogeneic | other malignancy | hematology | 2017 | standard therapy | France | 59 |
| 2077 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Lithuania | 53 |
| 2078 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 44 |
| 2079 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2017 | standard therapy | Poland | 32 |
| 2080 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 22 |
| 2081 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 53 |
| 2082 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2017 | standard therapy | Poland | 27 |
| 2083 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 49 |
| 2084 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 60 |
| 2085 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 64 |
| 2086 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 31 |
| 2087 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 57 |
| 2088 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 30 |
| 2089 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2017 | standard therapy | USA | 74 |
| 2090 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Poland | 52 |
| 2091 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 64 |
| 2092 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Belgium | 70 |
| 2093 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Poland | 53 |
| 2094 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 35 |
| 2095 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 51 |
| 2096 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 65 |
| 2097 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 60 |
| 2098 | peripheral blood | allogeneic | primary Immunodeficiency | hematology | 2017 | standard therapy | Russia | 2 |
| 2099 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | USA | 62 |
| 2100 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 49 |
| 2101 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Canada | 41 |
| 2102 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 52 |
| 2103 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 76 |
| 2104 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 68 |
| 2105 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 55 |
| 2106 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 25 |
| 2107 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Poland | 58 |
| 2108 | peripheral blood | allogeneic | myeloproliferative neoplasms | hematology | 2017 | standard therapy | Poland | 7 |
| 2109 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 42 |
| 2110 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Canada | 4 |
| 2111 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Israel | 11 |
| 2112 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Netherlands | 69 |
| 2113 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 68 |
| 2114 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 43 |
| 2115 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Switzerland | 67 |
| 2116 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 19 |
| 2117 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 69 |
| 2118 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Netherlands | 51 |
| 2119 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 58 |
| 2120 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 67 |
| 2121 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | USA | 58 |
| 2122 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 65 |
| 2123 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 62 |
| 2124 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 39 |
| 2125 | peripheral blood | allogeneic | primary Immunodeficiency | hematology | 2017 | standard therapy | Russia | 4 |
| 2126 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | France | 63 |
| 2127 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 63 |
| 2128 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Kanada | 32 |
| 2129 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | USA | 62 |
| 2130 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 7 |
| 2131 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Poland | 36 |
| 2132 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Hungary | 32 |
| 2133 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 38 |
| 2134 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 38 |
| 2135 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 49 |
| 2136 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 60 |
| 2137 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Netherlands | 51 |
| 2138 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Turkey | 54 |
| 2139 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 58 |
| 2140 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Russia | 36 |
| 2141 | peripheral blood | allogeneic | chronic granulomatous disease | hematology | 2017 | standard therapy | Poland | 4 |
| 2142 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Germany | 65 |
| 2143 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 29 |
| 2144 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Czech Republic | 12 |
| 2145 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 63 |
| 2146 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Germany | 29 |
| 2147 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Finland | 46 |
| 2148 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 35 |
| 2149 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Slovakia | 54 |
| 2150 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 23 |
| 2151 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 65 |
| 2152 | peripheral blood | allogeneic | prolymphocytic leukemia | hematology | 2017 | standard therapy | Belgium | 38 |
| 2153 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 54 |
| 2154 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 39 |
| 2155 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 69 |
| 2156 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 64 |
| 2157 | peripheral blood | allogeneic | other myleofibrosis | hematology | 2017 | standard therapy | USA | 71 |
| 2158 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 35 |
| 2159 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | USA | 65 |
| 2160 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Canada | 63 |
| 2161 | peripheral blood | allogeneic | follicular CA | hematology | 2017 | standard therapy | South Africa | 42 |
| 2162 | peripheral blood | allogeneic | acute myelogenous leukemia with myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 64 |
| 2163 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Czech Republic | 62 |
| 2164 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 55 |
| 2165 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 53 |
| 2166 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Czech Republic | 48 |
| 2167 | peripheral blood | allogeneic | β - thalassemia major | hematology | 2017 | standard therapy | India | 4 |
| 2168 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 67 |
| 2169 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 67 |
| 2170 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 59 |
| 2171 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 62 |
| 2172 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | United Kingdom | 55 |
| 2173 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 59 |
| 2174 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 52 |
| 2175 | peripheral blood | allogeneic | myeloproliferative neoplasms | hematology | 2017 | standard therapy | Poland | 7 |
| 2176 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 68 |
| 2177 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Belgium | 34 |
| 2178 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 70 |
| 2179 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Estonia | 67 |
| 2180 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 30 |
| 2181 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 51 |
| 2182 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 69 |
| 2183 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Switzerland | 75 |
| 2184 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Lithuania | 65 |
| 2185 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Canada | 56 |
| 2186 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 55 |
| 2187 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 56 |
| 2188 | peripheral blood | allogeneic | osteopetrosis | hematology | 2017 | standard therapy | Israel | 3 |
| 2189 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Poland | 47 |
| 2190 | peripheral blood | allogeneic | B-cell Chronic lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 48 |
| 2191 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 65 |
| 2192 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Germany | 56 |
| 2193 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 64 |
| 2194 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 33 |
| 2195 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 67 |
| 2196 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 53 |
| 2197 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 60 |
| 2198 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 63 |
| 2199 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 42 |
| 2200 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 75 |
| 2201 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 32 |
| 2202 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Germany | 54 |
| 2203 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Italy | 58 |
| 2204 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 57 |
| 2205 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 50 |
| 2206 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | USA | 62 |
| 2207 | peripheral blood | allogeneic | aplastic anaemia | hematology | 2017 | standard therapy | United Kingdom | 23 |
| 2208 | peripheral blood | allogeneic | no data | hematology | 2017 | standard therapy | Poland | 39 |
| 2209 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Belgium | 55 |
| 2210 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 46 |
| 2211 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Belgium | 71 |
| 2212 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 64 |
| 2213 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 65 |
| 2214 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | USA | 45 |
| 2215 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Belgium | 19 |
| 2216 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Norway | 57 |
| 2217 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Brazil | 12 |
| 2218 | peripheral blood | allogeneic | hemophagocytosis | hematology | 2017 | standard therapy | USA | 52 |
| 2219 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 45 |
| 2220 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Lithuania | 59 |
| 2221 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | Germany | 56 |
| 2222 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 60 |
| 2223 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Sweden | 63 |
| 2224 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 61 |
| 2225 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Netherlands | 75 |
| 2226 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Netherlands | 66 |
| 2227 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 53 |
| 2228 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 46 |
| 2229 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 44 |
| 2230 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Germany | 66 |
| 2231 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Croatia | 64 |
| 2232 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Spain | 20 |
| 2233 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 3 |
| 2234 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Italy | 47 |
| 2235 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | France | 56 |
| 2236 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 48 |
| 2237 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | France | 43 |
| 2238 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 47 |
| 2239 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 53 |
| 2240 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 32 |
| 2241 | peripheral blood | allogeneic | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Belgium | 57 |
| 2242 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Slovakia | 64 |
| 2243 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 75 |
| 2244 | peripheral blood | allogeneic | Langerhans Lymphohistiocytosis | hematology | 2017 | standard therapy | Czech Republic | 2 |
| 2245 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 54 |
| 2246 | peripheral blood | allogeneic | no data | n/a | 2017 | standard therapy | France | 39 |
| 2247 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Hungary | 47 |
| 2248 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Denmark | 63 |
| 2249 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Austria | 54 |
| 2250 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 48 |
| 2251 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 56 |
| 2252 | peripheral blood | allogeneic | diffuse large B-cell lymphoma | hematology | 2017 | standard therapy | Germany | 61 |
| 2253 | peripheral blood | allogeneic | myelofibrosis | hematology | 2017 | standard therapy | Spain | 63 |
| 2254 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 65 |
| 2255 | peripheral blood | allogeneic | Common variable immunodeficiency, relapsed hemophagocytic syndrome | hematology | 2017 | standard therapy | Germany | 44 |
| 2256 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 63 |
| 2257 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 3 |
| 2258 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Iran | 17 |
| 2259 | peripheral blood | allogeneic | Niemann–Pick disease | hematology | 2017 | standard therapy | Poland | 2 |
| 2260 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2017 | standard therapy | Poland | 14 |
| 2261 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2017 | standard therapy | Turkey | 29 |
| 2262 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 68 |
| 2263 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 43 |
| 2264 | peripheral blood | allogeneic | chronic myeloproliferative neoplasm blast crisis | hematology | 2017 | standard therapy | Germany | 29 |
| 2265 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2017 | standard therapy | United Kingdom | 51 |
| 2266 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 24 |
| 2267 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 60 |
| 2268 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2017 | standard therapy | Germany | 44 |
| 2269 | peripheral blood | allogeneic | Hurler syndrome | hematology | 2017 | standard therapy | United Kingdom | 2 |
| 2270 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 66 |
| 2271 | peripheral blood | allogeneic | severe aplastic anaemia | hematology | 2016 | standard therapy | Russia | 18 |
| 2272 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 35 |
| 2273 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | USA | 69 |
| 2274 | peripheral blood | allogeneic | T-cell-prolymphocytic leukemia | hematology | 2016 | standard therapy | United Kingdom | 61 |
| 2275 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 19 |
| 2276 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 63 |
| 2277 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 62 |
| 2278 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 67 |
| 2279 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Canada | 47 |
| 2280 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 47 |
| 2281 | peripheral blood | allogeneic | plasma cell disorder | hematology | 2016 | standard therapy | France | 54 |
| 2282 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Spain | 50 |
| 2283 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 21 |
| 2284 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Netherlands | 39 |
| 2285 | peripheral blood | allogeneic | acute myelogenous leukemia M2/M4 | hematology | 2016 | standard therapy | Germany | 59 |
| 2286 | peripheral blood | allogeneic | high-risk acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 5 |
| 2287 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Italy | 58 |
| 2288 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 33 |
| 2289 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 30 |
| 2290 | peripheral blood | allogeneic | composite lymphoma | hematology | 2016 | standard therapy | Germany | 51 |
| 2291 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 55 |
| 2292 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 62 |
| 2293 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Russia | 32 |
| 2294 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 59 |
| 2295 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Russia | 44 |
| 2296 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 37 |
| 2297 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 15 |
| 2298 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2016 | standard therapy | Germany | 40 |
| 2299 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Greece | 9 |
| 2300 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 24 |
| 2301 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 54 |
| 2302 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 56 |
| 2303 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 63 |
| 2304 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 68 |
| 2305 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 72 |
| 2306 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Poland | 58 |
| 2307 | peripheral blood | allogeneic | B-cell Acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belgium | 44 |
| 2308 | peripheral blood | allogeneic | myelofibrosis | hematology | 2016 | standard therapy | France | 67 |
| 2309 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 20 |
| 2310 | peripheral blood | allogeneic | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Russia | 38 |
| 2311 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 66 |
| 2312 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 50 |
| 2313 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2016 | standard therapy | Finland | 46 |
| 2314 | peripheral blood | allogeneic | SAA / Amyloidosis | hematology | 2016 | standard therapy | United Kingdom | 45 |
| 2315 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | France | 59 |
| 2316 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Portugal | 41 |
| 2317 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 65 |
| 2318 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Australia | 62 |
| 2319 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | New Zealand | 59 |
| 2320 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Austria | 61 |
| 2321 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 39 |
| 2322 | peripheral blood | allogeneic | myeloma multiplex | hematology | 2016 | standard therapy | Poland | 38 |
| 2323 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Belgium | 9 |
| 2324 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Slovakia | 30 |
| 2325 | peripheral blood | allogeneic | lymphoblastic lymphoma | hematology | 2016 | standard therapy | Italy | 33 |
| 2326 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 53 |
| 2327 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 65 |
| 2328 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 28 |
| 2329 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Turkey | 51 |
| 2330 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 61 |
| 2331 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | France | 60 |
| 2332 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Brazil | 37 |
| 2333 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | United Kingdom | 20 |
| 2334 | peripheral blood | allogeneic | primary myelofibrosis | hematology | 2016 | standard therapy | Switzerland | 67 |
| 2335 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Austria | 41 |
| 2336 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 60 |
| 2337 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 44 |
| 2338 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 63 |
| 2339 | peripheral blood | allogeneic | myeloproliferative syndrome | hematology | 2016 | standard therapy | Poland | 52 |
| 2340 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Serbia | 21 |
| 2341 | peripheral blood | allogeneic | leukemia | hematology | 2016 | standard therapy | Lithuania | 53 |
| 2342 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Turkey | 4 |
| 2343 | peripheral blood | allogeneic | chronic myelomonocytic leukaemia | hematology | 2016 | standard therapy | Finland | 53 |
| 2344 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Italy | 52 |
| 2345 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Spain | 15 |
| 2346 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Denmark | 68 |
| 2347 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
| 2348 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Israel | 36 |
| 2349 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Switzerland | below 1 |
| 2350 | peripheral blood | allogeneic | myelofibrosis | hematology | 2016 | standard therapy | Netherlands | 66 |
| 2351 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Belgium | 65 |
| 2352 | peripheral blood | allogeneic | myelodysplastic syndrome - RCMD | hematology | 2016 | standard therapy | Czech Republic | 32 |
| 2353 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 59 |
| 2354 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | United Kingdom | 68 |
| 2355 | peripheral blood | allogeneic | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 19 |
| 2356 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 32 |
| 2357 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Poland | 55 |
| 2358 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 67 |
| 2359 | peripheral blood | allogeneic | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 61 |
| 2360 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Turkey | 48 |
| 2361 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Netherlands | 38 |
| 2362 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 18 |
| 2363 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 46 |
| 2364 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 65 |
| 2365 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Turkey | 38 |
| 2366 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
| 2367 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Turkey | 37 |
| 2368 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Israel | 63 |
| 2369 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Turkey | 55 |
| 2370 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 30 |
| 2371 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 27 |
| 2372 | peripheral blood | allogeneic | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Germany | 32 |
| 2373 | peripheral blood | allogeneic | chronic myeloid leukemia | hematology | 2016 | standard therapy | Germany | 62 |
| 2374 | peripheral blood | allogeneic | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Lithuania | 23 |
| 2375 | peripheral blood | allogeneic | acute myelogenous leukemia | hematology | 2016 | standard therapy | Spain | 38 |
| 2376 | peripheral blood | allogeneic | no data | n/a | 2016 | standard therapy | Netherlands | 58 |
| 2377 | peripheral blood |